[{"status": "Ongoing", "city": "Cranford", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA214019"], "brand_name": ["DAPSONE"], "generic_name": ["DAPSONE"], "manufacturer_name": ["Viona Pharmaceuticals Inc"], "product_ndc": ["72578-094"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TOPICAL"], "substance_name": ["DAPSONE"], "rxcui": ["1741905"], "spl_id": ["fbed711e-945e-46aa-8883-fee0b7604485"], "spl_set_id": ["30867c69-cf3c-4360-8e56-db96e0b0c3ab"], "package_ndc": ["72578-094-01", "72578-094-02", "72578-094-03"], "is_original_packager": [true], "nui": ["N0000175881", "M0020791"], "pharm_class_epc": ["Sulfone [EPC]"], "pharm_class_cs": ["Sulfones [CS]"], "unii": ["8W5C518302"]}, "product_type": "Drugs", "event_id": "95650", "recalling_firm": "VIONA PHARMACEUTICALS INC", "address_1": "20 Commerce Dr Ste 340", "address_2": "N/A", "postal_code": "07016-3617", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide", "recall_number": "D-0038-2025", "product_description": "Dapsone Gel 7.5%, 60 gram pump, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India, Distributed by: Viona Pharmaceuticals Inc., Cranford, NJ 07016, NDC 72578-094-02.", "product_quantity": "6048 pumps", "reason_for_recall": "Crystallization", "recall_initiation_date": "20241029", "center_classification_date": "20241105", "report_date": "20241113", "code_info": "Lots T401151, Exp, 06/30/2026; T400806, Exp 03/31/2026", "more_code_info": ""}, {"status": "Ongoing", "city": "Gibbstown", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M022"], "brand_name": ["GELATO TOPICAL ANESTHETIC"], "generic_name": ["BENZOCAINE"], "manufacturer_name": ["Mycone Dental Supply Co., Inc DBA Keystone Industries and Deepak Products Inc"], "product_ndc": ["68400-352"], "product_type": ["HUMAN OTC DRUG"], "route": ["DENTAL"], "substance_name": ["BENZOCAINE"], "rxcui": ["238910", "727988"], "spl_id": ["0bf1220f-a6ad-8a62-e063-6394a90af47e"], "spl_set_id": ["1f8431bb-f33c-4fd8-9472-9b59ffb5f18e"], "package_ndc": ["68400-352-30"], "is_original_packager": [true], "nui": ["N0000185508", "N0000175629", "N0000184306", "M0000728"], "pharm_class_epc": ["Standardized Chemical Allergen [EPC]"], "pharm_class_pe": ["Increased Histamine Release [PE]", "Cell-mediated Immunity [PE]"], "pharm_class_cs": ["Allergens [CS]"], "unii": ["U3RSY48JW5"]}, "product_type": "Drugs", "event_id": "95854", "recalling_firm": "Keystone Industries", "address_1": "480 S Democrat Rd", "address_2": "", "postal_code": "08027-1239", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the USA and Canada, Dominican Republic, El Salvador, Honduras, and Qatar.", "recall_number": "D-0137-2025", "product_description": "Gelato, Benzocaine 20% Topical Gel Anesthetic Gel, Net Wt. 1 oz. (30ml), Manufactured by Keystone Industries 480 S. Democrat Rd., Gibbstown, NJ 08027, NDC# 68400-352-30.", "product_quantity": "", "reason_for_recall": "CGMP deviations: the bulk product was rejected by the Quality Unit after routine inspection of the mixing vessel showed scratches on the sides and bottom of the mixing vessel. Product was to be rejected but was inadvertently released and shipped to customers.", "recall_initiation_date": "20241114", "center_classification_date": "20241213", "report_date": "20241225", "code_info": "Lot: BNZ-001646, Exp Date: 11/26/2026, Keystone item No. 03-02319", "more_code_info": ""}, {"status": "Ongoing", "city": "Quzhou", "state": "", "country": "China", "classification": "Class II", "openfda": {"application_number": ["M003"], "brand_name": ["FIRST AID ANTISEPTIC"], "generic_name": ["POVIDONE-IODINE"], "manufacturer_name": ["Rugby Laboratories"], "product_ndc": ["0536-1271"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["POVIDONE-IODINE"], "rxcui": ["312563"], "spl_id": ["38911ca2-7c18-5096-e063-6394a90a6121"], "spl_set_id": ["b2bcb69e-8ffb-23ee-e053-2995a90aee21"], "package_ndc": ["0536-1271-80"], "is_original_packager": [true], "upc": ["0305361271800"], "nui": ["N0000175486", "M0011640"], "pharm_class_epc": ["Antiseptic [EPC]"], "pharm_class_cs": ["Iodine [CS]"], "unii": ["85H0HZU99M"]}, "product_type": "Drugs", "event_id": "95422", "recalling_firm": "Zhejiang Jingwei Pharmaceutical Co., Ltd.", "address_1": "Wengjia Road, Changshan Industrial Park No.19", "address_2": "", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed to one wholesaler in OH for Nationwide distribution.", "recall_number": "D-0013-2025", "product_description": "First Aid Antiseptic Ointment, Povidone Iodine USP 10%, Inactive Ingredients: mineral oil, petrolatum. NET Wt. 1 OZ (28.4 g) per tube, Distributed by: Rugby Laboratories, Indianapolis, IN 46268. Made in China. NDC:  0536-1271-80", "product_quantity": "295,164 tubes", "reason_for_recall": "Incorrect/Undeclared Excipients: The inactive ingredients labeled on the product boxes and tubes are listed as \"mineral oil , petrolatum \". The inactive ingredients in the actual product are polyethylene glycol 400 , polyethylene glycol 4000.", "recall_initiation_date": "20240911", "center_classification_date": "20241017", "report_date": "20241023", "code_info": "Lot, expiry:   Lot 220901, Exp. 09/30/2024; Lot 230701, Exp. 07/31/2026; Lot 230301, Exp. 03/31/2026; Lot 230401, Exp. 04/30/2026; Lot 230501, Exp. 05/31/2026; Lot 230801, Exp. 08/31/2026; Lot 240301, Exp. 03/31/2027; Lot 240501, Exp. 04/30/2027.", "more_code_info": ""}, {"status": "Ongoing", "city": "Canonsburg", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA076187"], "brand_name": ["LEVOTHYROXINE SODIUM"], "generic_name": ["LEVOTHYROXINE SODIUM"], "manufacturer_name": ["Mylan Pharmaceuticals Inc."], "product_ndc": ["0378-1800", "0378-1803", "0378-1805", "0378-1807", "0378-1809", "0378-1811", "0378-1813", "0378-1823", "0378-1815", "0378-1817", "0378-1819", "0378-1821"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LEVOTHYROXINE SODIUM"], "rxcui": ["892246", "892251", "892255", "966220", "966221", "966222", "966224", "966225", "966248", "966249", "966253", "966270"], "spl_id": ["ca193039-55b1-4a7e-aa67-c4bff4f9f5b0"], "spl_set_id": ["e95720f2-91c9-a6d0-f7d5-8bcb94d07bbc"], "package_ndc": ["0378-1800-77", "0378-1800-10", "0378-1803-77", "0378-1803-10", "0378-1805-77", "0378-1805-10", "0378-1807-77", "0378-1807-10", "0378-1809-77", "0378-1809-10", "0378-1811-77", "0378-1811-10", "0378-1813-77", "0378-1813-10", "0378-1823-77", "0378-1823-10", "0378-1815-77", "0378-1815-10", "0378-1817-77", "0378-1817-10", "0378-1819-77", "0378-1819-10", "0378-1821-77"], "is_original_packager": [true], "unii": ["9J765S329G"]}, "product_type": "Drugs", "event_id": "95768", "recalling_firm": "Viatris Inc", "address_1": "1000 Mylan Blvd", "address_2": "", "postal_code": "15317-5853", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States and Puerto Rico", "recall_number": "D-0120-2025", "product_description": "Levothyroxine Sodium Tablets USP, 150 mcg, packaged in a) 90-count bottles (NDC 0378-1815-77) and b) 1000-count bottles (NDC 0378-1815-10), Rx only, Manufactured for: Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A.", "product_quantity": "9,828 bottles", "reason_for_recall": "Superpotent Drug and Subpotent Drug: potency failures obtained", "recall_initiation_date": "20241118", "center_classification_date": "20241212", "report_date": "20241218", "code_info": "Lot #: a) 8177720, Exp. Date Jun 2025; b) 3200218, Exp. Date Jun 2025", "more_code_info": ""}, {"status": "Terminated", "city": "Minneapolis", "state": "MN", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "95736", "recalling_firm": "Padagis US LLC", "address_1": "3940 Quebec Ave N", "address_2": "N/A", "postal_code": "55427-1244", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0048-2025", "product_description": "Triamcinolone Acetonide Cream USP, 0.025%, 1 LB (454 g) per jar, Rx Only, Manufactured By Padagis, Minneapolis, MN 55427. NDC: 45802-0063-05", "product_quantity": "10,872 jars", "reason_for_recall": "Subpotent and Superpotent Drug. Out of specification assay results recorded as part of Uniformity of Container test during long-term stability testing.", "recall_initiation_date": "20241011", "center_classification_date": "20241118", "termination_date": "20250929", "report_date": "20241127", "code_info": "Lot #: 2024154238, 2024174344, Exp. Date 3/31/2026"}, {"status": "Ongoing", "city": "Deer Park", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M012"], "brand_name": ["CHLORPHENIRAMINE MALEATE 4MG"], "generic_name": ["CHLORPHENIRAMINE MALEATE 4MG"], "manufacturer_name": ["Athlete's Needs, Inc."], "product_ndc": ["53185-277"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["CHLORPHENIRAMINE MALEATE"], "rxcui": ["1363309"], "spl_id": ["3bbe161c-4342-40b5-82b6-5270ef0e31d3"], "spl_set_id": ["4d974959-25fc-4707-9b72-9afbf47b76f1"], "package_ndc": ["53185-277-24"], "is_original_packager": [true], "upc": ["0092617099706"], "unii": ["V1Q0O9OJ9Z"]}, "product_type": "Drugs", "event_id": "95590", "recalling_firm": "BLI International, Inc.", "address_1": "75 N Industry Ct", "address_2": "N/A", "postal_code": "11729-4601", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was shipped to two private label customers ( OH & MO) as a final packaged product.", "recall_number": "D-0029-2025", "product_description": "Chlorpheniramine Maleate 4 mg tablets, 24-count bottle, Manufactured For: Athlete's Needs, Novi, MI 48377, NDC 53185-277-24", "product_quantity": "4,901 cases/24 count each case", "reason_for_recall": "Superpotent Drug: Stability failure for assay at 6 months test time-point.", "recall_initiation_date": "20241021", "center_classification_date": "20241030", "report_date": "20241106", "code_info": "Lot # 24A27724, Exp 01/31/2027", "more_code_info": ""}, {"status": "Ongoing", "city": "Columbus", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95849", "recalling_firm": "Amerisource Health Services LLC", "address_1": "2550 John Glenn Ave Ste A", "address_2": "", "postal_code": "43217-1188", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "PA, OH, PR", "recall_number": "D-0101-2025", "product_description": "Duloxetine Delayed-Release Capsules, USP, 60 mg, Rx only, 1,000 count bottle, Manufactured by: Aurobindo Pharma Limited, Hyderabad-500 090, India, For BluePoint Laboratories   NDC 68001-415-08", "product_quantity": "8,561 bottles", "reason_for_recall": "CGMP Deviations: Presence of N-nitroso-duloxetine impurity above the recommended interim limit", "recall_initiation_date": "20241114", "center_classification_date": "20241203", "report_date": "20241211", "code_info": "Lot, expiry: DT6022159A, DT6022167A, DT6022168A, exp 11/30/2024; Lot DT6023034A, 12/31/2024; Lots DT6023050A, DT6023051A, DT6023063A, DT6023067A, exp 01/31/2025; Lots DT6023073A,  DT6023072A, exp 02/28/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Baltimore", "state": "MD", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95610", "recalling_firm": "Lupin Pharmaceuticals Inc.", "address_1": "Harborplace Tower", "address_2": "111 S Calvert St Fl 21st", "postal_code": "21202-6174", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to 30 wholesalers/distributors who may have further distributed the product nationwide.", "recall_number": "D-0054-2025", "product_description": "Ramipril Capsules USP 10 mg, a) 90 count (NDC 68180-591-09), b) 100 count NDC 68180-591-01), and c) 500 count (NDC 68180-591-02) bottles, Rx only, Manufactured for Lupin Pharmaceuticals, Inc., Baltimore, MD, Manufactured by Lupin Limited, Goa, India", "product_quantity": "357,414 bottles", "reason_for_recall": "CGMP Deviations: Active pharmaceutical ingredient was sourced from an unapproved vendor", "recall_initiation_date": "20241023", "center_classification_date": "20241119", "report_date": "20241127", "code_info": "a) NDC 68180-591-09;  Lots  G327086, exp. date 30-Sep-25 GA01065, exp. date 31-Dec-25,  b) NDC 68180-591-01 Lots  G325033, G324987, exp. date 31-Jul-25,  G325110, GA00956, GA01066, GA01126, exp. date 31-Dec-25,  GA03299, GA03288, GA03287, exp. date 31-Mar-26  c) NDC 68180-591-02 Lot GA05919, exp. date 31-Jul-26 G327131, exp. date 30-Sep-25"}, {"status": "Ongoing", "city": "Atlanta", "state": "GA", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "94949", "recalling_firm": "Supercore Products Group Inc.", "address_1": "230 Peachtree St Nw", "address_2": "Ste 2200", "postal_code": "30303-1534", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide US (2014), Israel (2), Canada (12), Republic of Kosovo (1), Pakistan (1), Australia (3), Morocco (1), United Kingdom (1)", "recall_number": "D-0004-2025", "product_description": "Gold Hard Steel Plus Liquid, 2 FL OZ bottles, UPC 787188873199", "product_quantity": "615", "reason_for_recall": "Marketed without an approved NDA/ANDA: FDA analysis found products to be tainted with undeclared acetaminophen and sildenafil.", "recall_initiation_date": "20240712", "center_classification_date": "20241002", "report_date": "20241009", "code_info": "All lots"}, {"status": "Ongoing", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA075682"], "brand_name": ["IBU"], "generic_name": ["IBUPROFEN"], "manufacturer_name": ["Dr. Reddy's Laboratories Limited"], "product_ndc": ["55111-682", "55111-683", "55111-684"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["IBUPROFEN"], "rxcui": ["197805", "197806", "197807", "206905", "206913", "206917"], "spl_id": ["a7977972-4353-9ca0-d419-e37039010e7d"], "spl_set_id": ["24731405-219c-79b4-ecf0-7d5fbfda94ba"], "package_ndc": ["55111-682-09", "55111-682-01", "55111-682-05", "55111-683-30", "55111-683-50", "55111-683-09", "55111-683-01", "55111-683-05", "55111-684-30", "55111-684-50", "55111-684-60", "55111-684-09", "55111-684-01", "55111-684-05"], "is_original_packager": [true], "nui": ["N0000000160", "M0001335", "N0000175722"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]"], "unii": ["WK2XYI10QM"]}, "product_type": "Drugs", "event_id": "95620", "recalling_firm": "Dr. Reddy's Laboratories, Inc.", "address_1": "107 College Rd E", "address_2": "N/A", "postal_code": "08540-6623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "N/A", "distribution_pattern": "USA Nationwide", "recall_number": "D-0047-2025", "product_description": "IBU (ibuprofen) 600 mg tablets, 500-count bottle, Rx Only,  Distributor: Dr. Reddy's Laboratories Inc., Princeton, NJ 08540, Made in India, NDC 55111-683-05", "product_quantity": "3416 botttles", "reason_for_recall": "Failed Tablet/Capsule Specifications", "recall_initiation_date": "20241029", "center_classification_date": "20241115", "report_date": "20241127", "code_info": "Lot #: C5406201, Exp 03/31/2028"}, {"status": "Ongoing", "city": "Athens", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95826", "recalling_firm": "Midlab Incorporated", "address_1": "140 Private Brand Way", "address_2": "", "postal_code": "37303-1401", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0090-2025", "product_description": "ROYALAB Germ Away Antibacterial Hand Soap, Chloroxylenol 0.1%, NET CONTENTS: ONE U.S. GALLON (3.78 L), Royal Papers, 2701 Hereford St., St. Louis, MO 63139", "product_quantity": "", "reason_for_recall": "cGMP Deviations: Out of specification results for micro in hand soap products.", "recall_initiation_date": "20241106", "center_classification_date": "20241202", "report_date": "20241211", "code_info": "Lot 0711241", "more_code_info": ""}, {"status": "Terminated", "city": "New Delhi", "state": "", "country": "India", "classification": "Class II", "openfda": {"application_number": ["M017"], "brand_name": ["THERA CARE COLD HOT MEDICATED PATCH"], "generic_name": ["MENTHOL"], "manufacturer_name": ["Veridian Healthcare"], "product_ndc": ["71101-954"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["MENTHOL"], "rxcui": ["420222"], "spl_id": ["20d6f5cc-2c81-74a0-e063-6394a90abfed"], "spl_set_id": ["b1ce129d-06a1-7755-e053-2995a90abd7d"], "package_ndc": ["71101-954-05"], "is_original_packager": [true], "upc": ["0845717008181", "845717008181"], "unii": ["L7T10EIP3A"]}, "product_type": "Drugs", "event_id": "95595", "recalling_firm": "Unexo Life Sciences Private Limited", "address_1": "B16, Sector 4, Bawana Industrial Area", "address_2": "", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0066-2025", "product_description": "THERACARE Cold Hot Medicated Patch, Menthol 5%, 5 patches per box, Manufactured for: Veridian Healthcare, LLC, Gurnee, IL  60031 NDC 71101-954-05, UPC 8 45717 00818 1", "product_quantity": "279,936 patches", "reason_for_recall": "cGMP Deviations", "recall_initiation_date": "20241024", "center_classification_date": "20241122", "termination_date": "20250916", "report_date": "20241204", "code_info": "UPC 8 45717 00818 1", "more_code_info": ""}, {"status": "Ongoing", "city": "East Windsor", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA206125"], "brand_name": ["CINACALCET"], "generic_name": ["CINACALCET"], "manufacturer_name": ["Aurobindo Pharma Limited"], "product_ndc": ["65862-831", "65862-832", "65862-833"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CINACALCET HYDROCHLORIDE"], "rxcui": ["432400", "432401", "432402"], "spl_id": ["5aadf0b6-2c49-48d4-8d22-2fbf99dbf4e6"], "spl_set_id": ["42e99112-c402-4662-877f-9e3a84dff9f2"], "package_ndc": ["65862-831-30", "65862-831-90", "65862-831-01", "65862-831-05", "65862-832-30", "65862-832-90", "65862-832-01", "65862-832-05", "65862-833-30", "65862-833-90", "65862-833-01", "65862-833-05"], "is_original_packager": [true], "unii": ["1K860WSG25"]}, "product_type": "Drugs", "event_id": "95730", "recalling_firm": "Aurobindo Pharma USA Inc", "address_1": "279 Princeton Hightstown Rd", "address_2": "", "postal_code": "08520-1401", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide", "recall_number": "D-0078-2025", "product_description": "Cinacalcet Tablets, 60mg, packaged in: a) 30-count HDPE bottle (NDC 65862-832-30), b) 500-count HDPE bottle (NDC 65862-832-05), Rx Only, Distributed by: Aurobindo Pharma USA, Inc. 279 Princeton-Hightstown Road, East Windsor, NJ 08520, Made in India.", "product_quantity": "3336 bottles", "reason_for_recall": "cGMP Deviations: Presence of N-nitroso Cinacalcet impurity above FDA recommended interim limit", "recall_initiation_date": "20241107", "center_classification_date": "20241129", "report_date": "20241211", "code_info": "Lot #: a) CFSB23001A, Exp 03/31/2025, CFSB23002A, Exp 07/31/2025; CFSB23003A, Exp 10/31/2025; CFSB23004A, Exp 10/31/2025; b) P2300196, 12/31/2024", "more_code_info": ""}, {"status": "Terminated", "city": "Foster City", "state": "CA", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["NDA214787"], "brand_name": ["VEKLURY"], "generic_name": ["REMDESIVIR"], "manufacturer_name": ["Gilead Sciences, Inc."], "product_ndc": ["61958-2901", "61958-2902"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["REMDESIVIR"], "rxcui": ["2284960", "2367758", "2395502", "2395504"], "spl_id": ["22c8a187-b9a5-4b14-bae2-7d9286fae9ce"], "spl_set_id": ["c0978fa8-53ff-4ca2-82a7-567fd3e958ca"], "package_ndc": ["61958-2902-2", "61958-2901-2"], "is_original_packager": [true], "nui": ["N0000193948"], "pharm_class_epc": ["SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC]"], "unii": ["3QKI37EEHE"]}, "product_type": "Drugs", "event_id": "95399", "recalling_firm": "Gilead Sciences, Inc.", "address_1": "333 Lakeside Dr", "address_2": "N/A", "postal_code": "94404-1147", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the U.S.A.", "recall_number": "D-0005-2025", "product_description": "Veklury (remdesivir) for injection, 100 mg/vial, Single-Dose Vial, Rx only, Manufactured for: Gilead Sciences, Inc., Foster City, CA 94404, NDC 61958-2901-2", "product_quantity": "105,000 vials", "reason_for_recall": "Presence of Particulate Matter: Presence of glass particle.", "recall_initiation_date": "20240919", "center_classification_date": "20241003", "termination_date": "20250729", "report_date": "20241009", "code_info": "Lot: 47035CFA, Exp. 11/2025"}, {"status": "Terminated", "city": "New Delhi", "state": "", "country": "India", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95595", "recalling_firm": "Unexo Life Sciences Private Limited", "address_1": "B16, Sector 4, Bawana Industrial Area", "address_2": "", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0062-2025", "product_description": "ABSORBINE jr. Extra Large BACK PATCH, Menthol 5%, 1 extra large patch per box, Distributed By: Absorbine Jr., LLC, Chattanooga, TN 37402 UPC 8 89476 41218 6, UPC 8 89476 41236 0", "product_quantity": "6,848,820 patches", "reason_for_recall": "cGMP Deviations", "recall_initiation_date": "20241024", "center_classification_date": "20241122", "termination_date": "20250916", "report_date": "20241204", "code_info": "UPC 8 89476 41218 6, UPC 8 89476 41236 0", "more_code_info": ""}, {"status": "Terminated", "city": "Canton", "state": "MA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95427", "recalling_firm": "Fresenius Kabi Compounding, LLC", "address_1": "20 Dan Rd", "address_2": "N/A", "postal_code": "02021-2809", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to 125 direct accounts nationwide.", "recall_number": "D-0020-2025", "product_description": "NORepinephrine Bitartrate 0.9% Sodium Chloride Injection USP, 8 mg per 250 mL, Single Dose Bag, Rx only, Fagron Sterile Services, Canton, MA NDC: 71506-027-58", "product_quantity": "733 bags", "reason_for_recall": "cGMP violations", "recall_initiation_date": "20240925", "center_classification_date": "20241021", "termination_date": "20250815", "report_date": "20241030", "code_info": "Lot # C274-000038404, exp. date 18-Nov-24", "more_code_info": ""}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA212317"], "brand_name": ["DILTIAZEM HYDROCHLORIDE"], "generic_name": ["DILTIAZEM HYDROCHLORIDE"], "manufacturer_name": ["Northstar Rx LLC"], "product_ndc": ["16714-553", "16714-554", "16714-555"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DILTIAZEM HYDROCHLORIDE"], "rxcui": ["830865", "830869", "830872"], "spl_id": ["a11626b3-d7a9-43b0-85d4-38a582acd661"], "spl_set_id": ["e2511ffe-5821-4f64-a469-f8ef9618b1b5"], "package_ndc": ["16714-553-01", "16714-554-01", "16714-555-01"], "is_original_packager": [true], "upc": ["0316714554013", "0316714553016", "0316714555010"], "unii": ["OLH94387TE"]}, "product_type": "Drugs", "event_id": "95660", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0097-2025", "product_description": "Diltiazem Hydrochloride Extended-Release Capsules, USP 90mg, Twice-a-Day Dosage, Rx Only, 100 Capsules per bottle, Mfd for: Northstar Rx LLC, Memphis, TN, Mfd by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh India, NDC 16714-554-01.", "product_quantity": "4704 bottles", "reason_for_recall": "cGMP Deviations: Presence of N-nitroso-Desmethyl-Diltiazem impurity above FDA recommended interim limit.", "recall_initiation_date": "20241101", "center_classification_date": "20241203", "report_date": "20241211", "code_info": "Lot #: 17222452, Exp Date 11/30/2024; 17230607, Exp Date 02/28/2025.", "more_code_info": ""}, {"status": "Completed", "city": "La Vergne", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95705", "recalling_firm": "The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories", "address_1": "341 Mason Rd", "address_2": "N/A", "postal_code": "37086-3606", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0050-2025", "product_description": "Guaifenesin Dextromethorphan Syrup, 100 mg/10mg per 5 mL, Major Pharmaceuticals 8401 Bearing Drive, Suite 100, Indianapolis, IN, 46268, NDC 0904-7134-70", "product_quantity": "N/A", "reason_for_recall": "Failed Impurity/Degradation Specifications", "recall_initiation_date": "20241107", "center_classification_date": "20241118", "report_date": "20241127", "code_info": "Lot #: C00113, Exp. Date 11/2024; C00125, Exp. Date 04/2025; C00145, Exp. Date 07/2025"}, {"status": "Ongoing", "city": "East Windsor", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA206125"], "brand_name": ["CINACALCET"], "generic_name": ["CINACALCET"], "manufacturer_name": ["Aurobindo Pharma Limited"], "product_ndc": ["65862-831", "65862-832", "65862-833"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CINACALCET HYDROCHLORIDE"], "rxcui": ["432400", "432401", "432402"], "spl_id": ["5aadf0b6-2c49-48d4-8d22-2fbf99dbf4e6"], "spl_set_id": ["42e99112-c402-4662-877f-9e3a84dff9f2"], "package_ndc": ["65862-831-30", "65862-831-90", "65862-831-01", "65862-831-05", "65862-832-30", "65862-832-90", "65862-832-01", "65862-832-05", "65862-833-30", "65862-833-90", "65862-833-01", "65862-833-05"], "is_original_packager": [true], "unii": ["1K860WSG25"]}, "product_type": "Drugs", "event_id": "95730", "recalling_firm": "Aurobindo Pharma USA Inc", "address_1": "279 Princeton Hightstown Rd", "address_2": "", "postal_code": "08520-1401", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide", "recall_number": "D-0077-2025", "product_description": "Cinacalcet Tablets, 30 mg, packaged in: a) 30-count HDPE bottle (NDC 65862-831-30); b) 500-count HDPE bottle (NDC 65862-831-05), Rx Only, Distributed by: Aurobindo Pharma USA, Inc. 279 Princeton-Hightstown Road, East Windsor, NJ 08520, Made in India.", "product_quantity": "102576 bottles", "reason_for_recall": "cGMP Deviations: Presence of N-nitroso Cinacalcet impurity above FDA recommended interim limit", "recall_initiation_date": "20241107", "center_classification_date": "20241129", "report_date": "20241211", "code_info": "Lot #: a) CFSA23001A, CFSA23002A, CFSA23003A, Exp 03/31/2025;  CFSA23004A, Exp 07/31/2025; CFSA23005A, Exp 10/31/2025; b) P2300191, P2300192, P2300193, P2300194, Exp 12/31/2024", "more_code_info": ""}, {"status": "Ongoing", "city": "Canonsburg", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA076187"], "brand_name": ["LEVOTHYROXINE SODIUM"], "generic_name": ["LEVOTHYROXINE SODIUM"], "manufacturer_name": ["Mylan Pharmaceuticals Inc."], "product_ndc": ["0378-1800", "0378-1803", "0378-1805", "0378-1807", "0378-1809", "0378-1811", "0378-1813", "0378-1823", "0378-1815", "0378-1817", "0378-1819", "0378-1821"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LEVOTHYROXINE SODIUM"], "rxcui": ["892246", "892251", "892255", "966220", "966221", "966222", "966224", "966225", "966248", "966249", "966253", "966270"], "spl_id": ["ca193039-55b1-4a7e-aa67-c4bff4f9f5b0"], "spl_set_id": ["e95720f2-91c9-a6d0-f7d5-8bcb94d07bbc"], "package_ndc": ["0378-1800-77", "0378-1800-10", "0378-1803-77", "0378-1803-10", "0378-1805-77", "0378-1805-10", "0378-1807-77", "0378-1807-10", "0378-1809-77", "0378-1809-10", "0378-1811-77", "0378-1811-10", "0378-1813-77", "0378-1813-10", "0378-1823-77", "0378-1823-10", "0378-1815-77", "0378-1815-10", "0378-1817-77", "0378-1817-10", "0378-1819-77", "0378-1819-10", "0378-1821-77"], "is_original_packager": [true], "unii": ["9J765S329G"]}, "product_type": "Drugs", "event_id": "95768", "recalling_firm": "Viatris Inc", "address_1": "1000 Mylan Blvd", "address_2": "", "postal_code": "15317-5853", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States and Puerto Rico", "recall_number": "D-0127-2025", "product_description": "Levothyroxine Sodium Tablets USP, 100 mcg, packaged in a) 90-count bottles (NDC 0378-1809-77) and b) 1000-count bottles (NDC 0378-1809-10), Rx only, Manufactured for: Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A.", "product_quantity": "65,169", "reason_for_recall": "Superpotent Drug and Subpotent Drug: potency failures obtained", "recall_initiation_date": "20241118", "center_classification_date": "20241212", "report_date": "20241218", "code_info": "Lot #: a) 8171269, Exp. Date Feb 2025; 8179579, Exp. Date July 2025 b)3183815, Exp. Date Nov 2024; 3189147, Exp. Date Jan 2025; 3192027, Exp. Date Feb 2025; 3202894, Exp. Date Jul 2025; 3192026, Exp. Date Feb 2025; 3199781, Exp. Date Jun 2025. 3192028, exp. date Feb 2025 3202895, exp. date July 2025", "more_code_info": ""}, {"status": "Terminated", "city": "New Delhi", "state": "", "country": "India", "classification": "Class II", "openfda": {"application_number": ["M017"], "brand_name": ["PARCHE LEON"], "generic_name": ["CAPSAICIN, CAMPHOR, MENTHOL"], "manufacturer_name": ["Pharmadel LLC"], "product_ndc": ["55758-039"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["CAMPHOR (SYNTHETIC)", "CAPSAICIN", "MENTHOL, UNSPECIFIED FORM"], "spl_id": ["3144b415-ab83-d639-e063-6294a90a7c93"], "spl_set_id": ["a8f266fa-6e43-559e-e053-2995a90a2c75"], "package_ndc": ["55758-039-01", "55758-039-06"], "is_original_packager": [true], "unii": ["5TJD82A1ET", "S07O44R1ZM", "L7T10EIP3A"], "upc": ["859424004336"]}, "product_type": "Drugs", "event_id": "95595", "recalling_firm": "Unexo Life Sciences Private Limited", "address_1": "B16, Sector 4, Bawana Industrial Area", "address_2": "", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0072-2025", "product_description": "PARCHE LEON PAIN RELIEVING HOT PATCH, Camphor 3%, Menthol 1.25%, Capsaicin 0.025%, 6 patches per box, Distributed by: Pharmadel LLC, Georgetown, DE 19947 NDC 55758-039-01, UPC 8 59424 00433 6", "product_quantity": "28,864 patches", "reason_for_recall": "cGMP Deviations", "recall_initiation_date": "20241024", "center_classification_date": "20241122", "termination_date": "20250916", "report_date": "20241204", "code_info": "UPC 8 59424 00433 6", "more_code_info": ""}, {"status": "Terminated", "city": "La Vergne", "state": "TN", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "95700", "recalling_firm": "The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories", "address_1": "341 Mason Rd", "address_2": "N/A", "postal_code": "37086-3606", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US.", "recall_number": "D-0045-2025", "product_description": "Hydralazine HCl Tablets, USP, 25mg, Rx only, 100 tablets per carton, Distributed by: Avet Pharmaceuticals Inc., East Brunswick, NJ 08816, Distributed by: MAJOR Pharmaceuticals, Livonia, MI, 48152, USA, NDC 0904-6441-61.", "product_quantity": "25814 tablets", "reason_for_recall": "Failed Impurities/Degradation Specifications; during routine stability testing for impurities.", "recall_initiation_date": "20241105", "center_classification_date": "20241114", "termination_date": "20250916", "report_date": "20241120", "code_info": "Lot#: T04888, Exp 11/2024; T04946, Exp 12/2024; T04970, Exp 07/2025"}, {"status": "Ongoing", "city": "Pulaski", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA213803"], "brand_name": ["SUNITINIB MALATE"], "generic_name": ["SUNITINIB MALATE"], "manufacturer_name": ["AvKARE"], "product_ndc": ["42291-901", "42291-902", "42291-903", "42291-904"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["SUNITINIB MALATE"], "rxcui": ["616279", "616285", "616289", "1541890"], "spl_id": ["0772f635-a03d-3c10-e063-6294a90a67ad"], "spl_set_id": ["0772eb61-ca42-39de-e063-6294a90a6632"], "package_ndc": ["42291-901-28", "42291-902-28", "42291-903-28", "42291-904-28"], "original_packager_product_ndc": ["0093-8199", "0093-8224", "0093-8229", "0093-8231"], "unii": ["LVX8N1UT73"]}, "product_type": "Drugs", "event_id": "95596", "recalling_firm": "AvKARE", "address_1": "615 N 1st St", "address_2": "", "postal_code": "38478-2403", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0103-2025", "product_description": "Sunitinib Malate Capsules, 12.5 mg, 28-count bottles, Rx Only, Manufactured for: AvKARE, Pulaski, TN 38478. NDC 42291-901-28", "product_quantity": "40 bottles", "reason_for_recall": "Labeling: Label Mix-Up", "recall_initiation_date": "20241018", "center_classification_date": "20241204", "report_date": "20241211", "code_info": "Lot #: 100049371, Exp. Date 07/31/2026", "more_code_info": ""}, {"status": "Ongoing", "city": "Gibbstown", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95854", "recalling_firm": "Keystone Industries", "address_1": "480 S Democrat Rd", "address_2": "", "postal_code": "08027-1239", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the USA and Canada, Dominican Republic, El Salvador, Honduras, and Qatar.", "recall_number": "D-0148-2025", "product_description": "Henry Schein, Benzo-Jel, Topical Anesthetic Gel, 20% Benzocaine, 1 fl. oz. (29.6 mL), Distributed by Henry Schein, Melville, NY 11747, For Professional Use Only,", "product_quantity": "", "reason_for_recall": "CGMP deviations: the bulk product was rejected by the Quality Unit after routine inspection of the mixing vessel showed scratches on the sides and bottom of the mixing vessel. Product was to be rejected but was inadvertently released and shipped to customers.", "recall_initiation_date": "20241114", "center_classification_date": "20241213", "report_date": "20241225", "code_info": "Lot: BNZ-001646, Exp Date: 11/26/2026, Keystone Item No. 03-43619", "more_code_info": ""}, {"status": "Ongoing", "city": "Gibbstown", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95854", "recalling_firm": "Keystone Industries", "address_1": "480 S Democrat Rd", "address_2": "", "postal_code": "08027-1239", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the USA and Canada, Dominican Republic, El Salvador, Honduras, and Qatar.", "recall_number": "D-0146-2025", "product_description": "Quala Dental Products, Topical Anesthetic Gel, Contains 20% Benzocaine, Net Contents: 1 oz (30g), Gluten Free, Quala Dental Products, Made in USA for: NDC, Inc, 407 New Sanford Road, La Vergne, TN 37086, www.quala.com", "product_quantity": "", "reason_for_recall": "CGMP deviations: the bulk product was rejected by the Quality Unit after routine inspection of the mixing vessel showed scratches on the sides and bottom of the mixing vessel. Product was to be rejected but was inadvertently released and shipped to customers.", "recall_initiation_date": "20241114", "center_classification_date": "20241213", "report_date": "20241225", "code_info": "Lot No.: BNZ-001646, Exp Date: 11/26/2026, Keystone Item No. 03-64419", "more_code_info": ""}, {"status": "Ongoing", "city": "Collegeville", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA212046"], "brand_name": ["DIHYDROERGOTAMINE MESYLATE"], "generic_name": ["DIHYDROERGOTAMINE MESYLATE"], "manufacturer_name": ["Provepharm Inc."], "product_ndc": ["81284-411"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR", "INTRAVENOUS", "SUBCUTANEOUS"], "substance_name": ["DIHYDROERGOTAMINE MESYLATE"], "rxcui": ["861672"], "spl_id": ["c3c6ccb7-6054-426c-8a56-d3c29dac13e2"], "spl_set_id": ["40b9ba9e-436e-444e-b078-01b12bb57ea7"], "package_ndc": ["81284-411-00", "81284-411-05", "81284-411-10"], "is_original_packager": [true], "upc": ["0381284411059"], "unii": ["81AXN7R2QT"]}, "product_type": "Drugs", "event_id": "95772", "recalling_firm": "Provepharm Inc.", "address_1": "100 Springhouse Dr Ste 105", "address_2": "", "postal_code": "19426-4709", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0150-2025", "product_description": "Dihydroergotamine Mesylate Injection, solution for injection, USP, 1 mg/mL Ampules, Rx Only, Distributed by: Provepharm Inc. 100 Springhouse Drive Suite 105, Collegeville, PA 19426, NDC 81284-411-05", "product_quantity": "2160 packs/5 ampules per pack = 10,800 ampules", "reason_for_recall": "Discoloration", "recall_initiation_date": "20241122", "center_classification_date": "20241216", "report_date": "20241225", "code_info": "Lot #: F9026F01, F9026F02, Exp. Date 12/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Rockford", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA076187"], "brand_name": ["LEVOTHYROXINE SODIUM"], "generic_name": ["LEVOTHYROXINE SODIUM"], "manufacturer_name": ["Mylan Institutional Inc."], "product_ndc": ["51079-440", "51079-444", "51079-441", "51079-442", "51079-443", "51079-445"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LEVOTHYROXINE SODIUM"], "rxcui": ["892246", "966220", "966221", "966222", "966224", "966225"], "spl_id": ["3a864332-4c4d-08a5-e063-6294a90aaaff"], "spl_set_id": ["5723c7a7-2a1d-4ab6-bf39-b2165ae781a6"], "package_ndc": ["51079-440-01", "51079-440-20", "51079-444-01", "51079-444-20", "51079-441-01", "51079-441-20", "51079-442-01", "51079-442-20", "51079-443-01", "51079-443-20", "51079-445-01", "51079-445-20"], "original_packager_product_ndc": ["0378-1803", "0378-1800", "0378-1805", "0378-1809", "0378-1813", "0378-1815"], "unii": ["9J765S329G"]}, "product_type": "Drugs", "event_id": "95817", "recalling_firm": "Mylan Institutional, Inc.", "address_1": "1718 Northrock Ct", "address_2": "", "postal_code": "61103-1201", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0133-2025", "product_description": "Levothyroxine Sodium Tablets, USP, 125 mcg (0.125 mg), 100 Tablets per carton (10 unit dose blister cards of 10 tablets each), Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 USA.  NDC: 51079-443-20", "product_quantity": "1,664 cartons", "reason_for_recall": "Subpotent and Superpotent Drug", "recall_initiation_date": "20241119", "center_classification_date": "20241212", "report_date": "20241218", "code_info": "Lot #: 3115893, Exp. Date 6/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Rockford", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA076187"], "brand_name": ["LEVOTHYROXINE SODIUM"], "generic_name": ["LEVOTHYROXINE SODIUM"], "manufacturer_name": ["Mylan Institutional Inc."], "product_ndc": ["42292-038", "42292-039", "42292-041", "42292-040"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LEVOTHYROXINE SODIUM"], "rxcui": ["966248", "966249", "966253", "966270"], "spl_id": ["3a991bf1-d9aa-b137-e063-6294a90af2cf"], "spl_set_id": ["cd69c192-cd3f-47e6-b0a6-c536ffed5c4b"], "package_ndc": ["42292-038-01", "42292-038-20", "42292-039-01", "42292-039-20", "42292-041-01", "42292-041-20", "42292-040-01", "42292-040-20"], "original_packager_product_ndc": ["0378-1807", "0378-1811", "0378-1823", "0378-1817"], "unii": ["9J765S329G"]}, "product_type": "Drugs", "event_id": "95817", "recalling_firm": "Mylan Institutional, Inc.", "address_1": "1718 Northrock Ct", "address_2": "", "postal_code": "61103-1201", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0136-2025", "product_description": "Levothyroxine Sodium Tablets, USP, 175 mcg (0.175 mg), 100 Tablets per carton (10 unit dose blister cards of 10 tablets each), Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 USA.  NDC: 42292-040-20", "product_quantity": "205 cartons", "reason_for_recall": "Subpotent and Superpotent Drug", "recall_initiation_date": "20241119", "center_classification_date": "20241212", "report_date": "20241218", "code_info": "Lot #: 3115869, Exp. Date 03/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Canonsburg", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA076187"], "brand_name": ["LEVOTHYROXINE SODIUM"], "generic_name": ["LEVOTHYROXINE SODIUM"], "manufacturer_name": ["Mylan Pharmaceuticals Inc."], "product_ndc": ["0378-1800", "0378-1803", "0378-1805", "0378-1807", "0378-1809", "0378-1811", "0378-1813", "0378-1823", "0378-1815", "0378-1817", "0378-1819", "0378-1821"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LEVOTHYROXINE SODIUM"], "rxcui": ["892246", "892251", "892255", "966220", "966221", "966222", "966224", "966225", "966248", "966249", "966253", "966270"], "spl_id": ["ca193039-55b1-4a7e-aa67-c4bff4f9f5b0"], "spl_set_id": ["e95720f2-91c9-a6d0-f7d5-8bcb94d07bbc"], "package_ndc": ["0378-1800-77", "0378-1800-10", "0378-1803-77", "0378-1803-10", "0378-1805-77", "0378-1805-10", "0378-1807-77", "0378-1807-10", "0378-1809-77", "0378-1809-10", "0378-1811-77", "0378-1811-10", "0378-1813-77", "0378-1813-10", "0378-1823-77", "0378-1823-10", "0378-1815-77", "0378-1815-10", "0378-1817-77", "0378-1817-10", "0378-1819-77", "0378-1819-10", "0378-1821-77"], "is_original_packager": [true], "unii": ["9J765S329G"]}, "product_type": "Drugs", "event_id": "95768", "recalling_firm": "Viatris Inc", "address_1": "1000 Mylan Blvd", "address_2": "", "postal_code": "15317-5853", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States and Puerto Rico", "recall_number": "D-0124-2025", "product_description": "Levothyroxine Sodium Tablets USP, 50 mcg, packaged in a) 90-count bottles (NDC 0378-1803-77) and b) 1000-count bottles (NDC 0378-1803-10), Rx only, Manufactured for: Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A.", "product_quantity": "42,331 bottles", "reason_for_recall": "Superpotent Drug and Subpotent Drug: potency failures obtained", "recall_initiation_date": "20241118", "center_classification_date": "20241212", "report_date": "20241218", "code_info": "Lot #: a) 8174701, Exp. Date April 2025; 8182228, Exp. Date Aug 2025 b)3193984, Exp. Date Mar 2025; 3206790, Exp. Date Aug 2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Rockford", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA076187"], "brand_name": ["LEVOTHYROXINE SODIUM"], "generic_name": ["LEVOTHYROXINE SODIUM"], "manufacturer_name": ["Mylan Institutional Inc."], "product_ndc": ["51079-440", "51079-444", "51079-441", "51079-442", "51079-443", "51079-445"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LEVOTHYROXINE SODIUM"], "rxcui": ["892246", "966220", "966221", "966222", "966224", "966225"], "spl_id": ["3a864332-4c4d-08a5-e063-6294a90aaaff"], "spl_set_id": ["5723c7a7-2a1d-4ab6-bf39-b2165ae781a6"], "package_ndc": ["51079-440-01", "51079-440-20", "51079-444-01", "51079-444-20", "51079-441-01", "51079-441-20", "51079-442-01", "51079-442-20", "51079-443-01", "51079-443-20", "51079-445-01", "51079-445-20"], "original_packager_product_ndc": ["0378-1803", "0378-1800", "0378-1805", "0378-1809", "0378-1813", "0378-1815"], "unii": ["9J765S329G"]}, "product_type": "Drugs", "event_id": "95817", "recalling_firm": "Mylan Institutional, Inc.", "address_1": "1718 Northrock Ct", "address_2": "", "postal_code": "61103-1201", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0131-2025", "product_description": "Levothyroxine Sodium Tablets, USP, 100 mcg (0.1 mg), 100 Tablets per carton (10 unit dose blister cards of 10 tablets each), Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 USA.  NDC: 51079-442-20", "product_quantity": "2,835 cartons", "reason_for_recall": "Subpotent and Superpotent Drug", "recall_initiation_date": "20241119", "center_classification_date": "20241212", "report_date": "20241218", "code_info": "Lot #: 3115936, Exp. Date 07/2025", "more_code_info": ""}, {"status": "Terminated", "city": "New Delhi", "state": "", "country": "India", "classification": "Class II", "openfda": {"application_number": ["M017"], "brand_name": ["THERACARE MAXIMUM STRENGTH PAIN RELIEF PATCH"], "generic_name": ["LIDOCAINE"], "manufacturer_name": ["Veridian Healthcare"], "product_ndc": ["71101-001"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["LIDOCAINE"], "rxcui": ["1737778"], "spl_id": ["28f04b12-7e69-bbd6-e063-6394a90a7792"], "spl_set_id": ["dfaf8a77-2276-4791-e053-2a95a90a3288"], "package_ndc": ["71101-001-06", "71101-001-24"], "is_original_packager": [true], "nui": ["N0000175682", "M0000897", "N0000175426", "N0000175976"], "pharm_class_epc": ["Amide Local Anesthetic [EPC]", "Antiarrhythmic [EPC]"], "pharm_class_cs": ["Amides [CS]"], "pharm_class_pe": ["Local Anesthesia [PE]"], "unii": ["98PI200987"], "upc": ["845717008785", "845717010566"]}, "product_type": "Drugs", "event_id": "95595", "recalling_firm": "Unexo Life Sciences Private Limited", "address_1": "B16, Sector 4, Bawana Industrial Area", "address_2": "", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0065-2025", "product_description": "THERACARE MAXIMUM STRENGTH PAIN RELIEF 4% LIDOCAINE PATCH, a) 1 patch (NDC 71101-001-24, UPC 8 45717 00878 5) and b) 6 patches (NDC 71101-001-06, UPC 8 45717 01056 6), Manufactured for: Veridian Healthcare, LLC, Gurnee, IL 60031", "product_quantity": "455,536 patches", "reason_for_recall": "cGMP Deviations", "recall_initiation_date": "20241024", "center_classification_date": "20241122", "termination_date": "20250916", "report_date": "20241204", "code_info": "a) UPC 8 45717 00878 5 b) UPC 8 45717 01056 6", "more_code_info": ""}, {"status": "Completed", "city": "La Vergne", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95705", "recalling_firm": "The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories", "address_1": "341 Mason Rd", "address_2": "N/A", "postal_code": "37086-3606", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0049-2025", "product_description": "Guaifenesin Dextromethorphan Syrup, 200 mg/20mg per 10 mL, Major Pharmaceuticals 8401 Bearing Drive, Suite 100, Indianapolis, IN, 46268, NDC 0904-7135-72", "product_quantity": "N/A", "reason_for_recall": "Failed Impurity/Degradation Specifications", "recall_initiation_date": "20241107", "center_classification_date": "20241118", "report_date": "20241127", "code_info": "Lot #: C00128, Exp. Date 04/2025; C00146, Exp.Date 07/2025"}, {"status": "Ongoing", "city": "Columbus", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95849", "recalling_firm": "Amerisource Health Services LLC", "address_1": "2550 John Glenn Ave Ste A", "address_2": "", "postal_code": "43217-1188", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "PA, OH, PR", "recall_number": "D-0100-2025", "product_description": "Duloxetine Delayed-Release Capsules, USP, 30 mg, Rx only, a) 30 count (NDC 68001-414-04) and b) 1,000 count (NDC 68001-414-08) bottles, Manufactured by: Aurobindo Pharma Limited, Hyderabad-500 090, India, For BluePoint Laboratories", "product_quantity": "23,490 bottles", "reason_for_recall": "CGMP Deviations: Presence of N-nitroso-duloxetine impurity above the recommended interim limit", "recall_initiation_date": "20241114", "center_classification_date": "20241203", "report_date": "20241211", "code_info": "a) 30 count; Lot, expiry: DT3023019B, DT3023020A, exp 01/31/2025 b) 1000 count; Lot, expiry: DTB23098A, exp 08/31/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA212317"], "brand_name": ["DILTIAZEM HYDROCHLORIDE"], "generic_name": ["DILTIAZEM HYDROCHLORIDE"], "manufacturer_name": ["GLENMARK PHARMACEUTICALS INC., USA"], "product_ndc": ["68462-562", "68462-850", "68462-851"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DILTIAZEM HYDROCHLORIDE"], "rxcui": ["830865", "830869", "830872"], "spl_id": ["52b392c0-72cb-4a91-8d27-5cacdb8a7778"], "spl_set_id": ["fb1606ea-1cff-46fd-b8e5-8135da76436c"], "package_ndc": ["68462-850-01", "68462-851-01", "68462-562-01"], "is_original_packager": [true], "upc": ["0368462562017", "0368462851012", "0368462850015"], "unii": ["OLH94387TE"]}, "product_type": "Drugs", "event_id": "95660", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0095-2025", "product_description": "Diltiazem Hydrochloride Extended-Release Capsules, USP 120 mg, Rx Only, 100 Capsules, Manufactured for: Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ 07430, Product of India, NDC 68462-562-01.", "product_quantity": "25584 bottles", "reason_for_recall": "cGMP Deviations: Presence of N-nitroso-Desmethyl-Diltiazem impurity above FDA recommended interim limit.", "recall_initiation_date": "20241101", "center_classification_date": "20241203", "report_date": "20241211", "code_info": "Lot #: 17222470, 17230680, 17222547, Exp. Date 11/30/2024; 17230304, Exp. Date, 12/31/2024; 17230598, Exp. Date, 02/2025.", "more_code_info": ""}, {"status": "Ongoing", "city": "Rockford", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA076187"], "brand_name": ["LEVOTHYROXINE SODIUM"], "generic_name": ["LEVOTHYROXINE SODIUM"], "manufacturer_name": ["Mylan Institutional Inc."], "product_ndc": ["51079-440", "51079-444", "51079-441", "51079-442", "51079-443", "51079-445"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LEVOTHYROXINE SODIUM"], "rxcui": ["892246", "966220", "966221", "966222", "966224", "966225"], "spl_id": ["3a864332-4c4d-08a5-e063-6294a90aaaff"], "spl_set_id": ["5723c7a7-2a1d-4ab6-bf39-b2165ae781a6"], "package_ndc": ["51079-440-01", "51079-440-20", "51079-444-01", "51079-444-20", "51079-441-01", "51079-441-20", "51079-442-01", "51079-442-20", "51079-443-01", "51079-443-20", "51079-445-01", "51079-445-20"], "original_packager_product_ndc": ["0378-1803", "0378-1800", "0378-1805", "0378-1809", "0378-1813", "0378-1815"], "unii": ["9J765S329G"]}, "product_type": "Drugs", "event_id": "95817", "recalling_firm": "Mylan Institutional, Inc.", "address_1": "1718 Northrock Ct", "address_2": "", "postal_code": "61103-1201", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0135-2025", "product_description": "Levothyroxine Sodium Tablets, USP, 150 mcg (0.150 mg), 100 Tablets per carton (10 unit dose blister cards of 10 tablets each), Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 USA.  NDC: 51079-445-20", "product_quantity": "690 cartons", "reason_for_recall": "Subpotent and Superpotent Drug", "recall_initiation_date": "20241119", "center_classification_date": "20241212", "report_date": "20241218", "code_info": "Lot #: 3115924, Exp. Date  06/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA208315"], "brand_name": ["MYCOPHENOLIC ACID"], "generic_name": ["MYCOPHENOLIC ACID"], "manufacturer_name": ["Ascend Laboratories, LLC"], "product_ndc": ["67877-426", "67877-427"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["MYCOPHENOLATE SODIUM"], "rxcui": ["485020", "485023"], "spl_id": ["3e021c3e-6b9c-41a2-987a-e6c60e3c4cf3"], "spl_set_id": ["2d9975e1-baee-4b0c-83de-8a0a92c5d075"], "package_ndc": ["67877-426-12", "67877-426-05", "67877-426-33", "67877-426-38", "67877-427-12", "67877-427-05", "67877-427-33", "67877-427-38"], "is_original_packager": [true], "upc": ["0367877427126"], "unii": ["WX877SQI1G"]}, "product_type": "Drugs", "event_id": "95275", "recalling_firm": "Ascend Laboratories, LLC", "address_1": "339 Jefferson Rd Ste 101", "address_2": "", "postal_code": "07054-3707", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and PR", "recall_number": "D-0668-2024", "product_description": "Mycophenolic Acid Delayed-Release Tablets USP, 360 mg, Rx Only, 120 Tablets per bottle, Manufactured by Alkem Laboratories, LTD, INDIA; Distributed by Ascend Laboratories, LLC, Parsippany, NJ 07054, NDC 67877-427-12.", "product_quantity": "117,493 bottles", "reason_for_recall": "Failed Dissolution Specifications", "recall_initiation_date": "20240903", "center_classification_date": "20240924", "report_date": "20241002", "code_info": "Lots 22123437, 22123438, 22123535, Exp Date 9/30/24; 22123536, 22123537, 22123538,  22123646, 22123647, Exp Date 10/31/24; 23120529, 23120530, Exp Date 1/31/25;  23120703, 23120705, Exp Date 2/28/25; 23121429, 23121726, 23122049, 23122097, Exp Date, 4/30/25; 23121984, 23121985, 23121986, Exp Date 5/31/25; 23122325, 23122329, 23122330, 23122331, Exp Date 6/30/26; 23122776, 23122852, 23122853, 23123154, 23123155, Exp Date 8/31/26; 23123458, Exp Date 9/30/26.", "more_code_info": ""}, {"status": "Ongoing", "city": "Dunn", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95390", "recalling_firm": "EnviroServe Chemicals Inc.", "address_1": "603 S Wilson Ave", "address_2": "", "postal_code": "28334-5832", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "", "distribution_pattern": "Product was sent to one distributor in North Carolina.", "recall_number": "D-0667-2024", "product_description": "EnviroClean Hand Sanitizer Gel (isopropyl alcohol 70% v/v), 473 mL (16 fl. oz.) bottles, EnviroServe Chemicals Inc., 603 South Wilson Avenue, Dunn NC, 28334, NDC 76563-3010-1", "product_quantity": "120 bottles", "reason_for_recall": "CGMP deviations", "recall_initiation_date": "20240918", "center_classification_date": "20240924", "report_date": "20241002", "code_info": "Lot #: 042224-L1, Exp. Date 04/22/2025", "more_code_info": ""}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["ANDA212918"], "brand_name": ["ATOVAQUONE"], "generic_name": ["ATOVAQUONE"], "manufacturer_name": ["Bionpharma Inc."], "product_ndc": ["69452-252"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ATOVAQUONE"], "rxcui": ["308429"], "spl_id": ["0d5fc0ab-9cfa-0a79-e063-6394a90a2b61"], "spl_set_id": ["bff4f4fc-6307-f414-e053-2a95a90ac0de"], "package_ndc": ["69452-252-87"], "is_original_packager": [true], "upc": ["0369452252871"], "nui": ["N0000175482", "N0000175485"], "pharm_class_epc": ["Antimalarial [EPC]", "Antiprotozoal [EPC]"], "unii": ["Y883P1Z2LT"]}, "product_type": "Drugs", "event_id": "95345", "recalling_firm": "Bionpharma Inc.", "address_1": "400 Alexander Park Ste 2-4b", "address_2": "", "postal_code": "08540-6539", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide in the U.S.A.", "recall_number": "D-0012-2025", "product_description": "Atovaquone Oral Suspension, USP 750 mg/5 mL, 210 mL bottle, Rx only, Distributed by: Bionpharma Inc., Princeton, NJ 08540, NDC # 69452-252-87.", "product_quantity": "1,980 bottles", "reason_for_recall": "Microbial Contamination of a Non-sterile Product: The product was found to be contaminated with Cohnella bacteria.", "recall_initiation_date": "20240917", "center_classification_date": "20241015", "termination_date": "20250916", "report_date": "20241023", "code_info": "Lot # 2310083, Exp. 09/30/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Shirley", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA021135"], "brand_name": ["VENOFER"], "generic_name": ["IRON SUCROSE"], "manufacturer_name": ["Fresenius Medical Care Holdings, Inc."], "product_ndc": ["49230-530", "49230-534"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["IRON SUCROSE"], "rxcui": ["1741267", "1741268", "1741270", "1741271"], "spl_id": ["e12cb876-ae80-416b-9bd3-a1cc83c9e666"], "spl_set_id": ["f1ab1a22-2b99-4d27-8b5a-9c3bcd5e3040"], "package_ndc": ["49230-530-01", "49230-530-10", "49230-530-25", "49230-534-01", "49230-534-10", "49230-534-25"], "is_original_packager": [true], "upc": ["0349230530254", "0349230534252"], "nui": ["M0011718", "N0000177913"], "pharm_class_cs": ["Iron [CS]"], "pharm_class_epc": ["Parenteral Iron Replacement [EPC]"], "unii": ["FZ7NYF5N8L"]}, "product_type": "Drugs", "event_id": "95711", "recalling_firm": "American Regent, Inc.", "address_1": "5 Ramsey Rd", "address_2": "", "postal_code": "11967-4701", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0080-2025", "product_description": "Venofer (iron sucrose) Injection, USP 100 mg Elemental Iron per 5 mL (20 mg/mL), 5 mL Single-Dose Vials, Rx Only, For Intravenous Use Only, Distributed by: Fresenius Medical Care NA, Waltham, MA 02451, NDC: 49230-534-01 (vial), NDC: 49230-534-25 (25 x 5 mL/vial cartons).", "product_quantity": "", "reason_for_recall": "Presence of Particulate Matter: Potential for glass delamination from the vials.", "recall_initiation_date": "20241111", "center_classification_date": "20241129", "report_date": "20241211", "code_info": "Lot#s: 4196, Exp 05/31/2026", "more_code_info": ""}, {"status": "Ongoing", "city": "Raleigh", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA212399"], "brand_name": ["LEVOTHYROXINE SODIUM"], "generic_name": ["LEVOTHYROXINE SODIUM"], "manufacturer_name": ["Accord Healthcare Inc."], "product_ndc": ["16729-447", "16729-458", "16729-448", "16729-449", "16729-451", "16729-450", "16729-452", "16729-453", "16729-454", "16729-455", "16729-456", "16729-457"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LEVOTHYROXINE SODIUM"], "rxcui": ["892246", "892251", "892255", "966220", "966221", "966222", "966224", "966225", "966248", "966249", "966253", "966270"], "spl_id": ["415fc774-31a5-124f-e063-6294a90a0e46"], "spl_set_id": ["a6233381-3043-4e9a-aaa6-a6b105e5142b"], "package_ndc": ["16729-458-15", "16729-458-17", "16729-447-15", "16729-447-17", "16729-448-15", "16729-448-17", "16729-449-15", "16729-449-17", "16729-451-15", "16729-451-17", "16729-450-15", "16729-450-17", "16729-452-15", "16729-452-17", "16729-453-15", "16729-453-17", "16729-454-15", "16729-454-17", "16729-455-15", "16729-455-17", "16729-456-15", "16729-456-17", "16729-457-15", "16729-457-17"], "is_original_packager": [true], "upc": ["0316729447157", "0316729449151", "0316729452151", "0316729454155", "0316729453158", "0316729448154", "0316729451154", "0316729457156", "0316729450157", "0316729456159", "0316729458153", "0316729455152"], "unii": ["9J765S329G"]}, "product_type": "Drugs", "event_id": "95747", "recalling_firm": "ACCORD HEALTHCARE, INC.", "address_1": "8041 Arco Corporate Dr Ste 200", "address_2": "", "postal_code": "27617-2010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide", "recall_number": "D-0076-2025", "product_description": "Levothyroxine Sodium Tablets, USP, 75 mcg (0.075 mg), 1000-count bottle, Rx Only, Manufactured for: Accord Healthcare, Inc., Durham, NC 27703, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, INDIA, NDC 16729-449-17", "product_quantity": "", "reason_for_recall": "Subpotent drug", "recall_initiation_date": "20241108", "center_classification_date": "20241129", "report_date": "20241211", "code_info": "Lot #: D2300191, Exp 12/31/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA212317"], "brand_name": ["DILTIAZEM HYDROCHLORIDE"], "generic_name": ["DILTIAZEM HYDROCHLORIDE"], "manufacturer_name": ["Northstar Rx LLC"], "product_ndc": ["16714-553", "16714-554", "16714-555"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DILTIAZEM HYDROCHLORIDE"], "rxcui": ["830865", "830869", "830872"], "spl_id": ["a11626b3-d7a9-43b0-85d4-38a582acd661"], "spl_set_id": ["e2511ffe-5821-4f64-a469-f8ef9618b1b5"], "package_ndc": ["16714-553-01", "16714-554-01", "16714-555-01"], "is_original_packager": [true], "upc": ["0316714554013", "0316714553016", "0316714555010"], "unii": ["OLH94387TE"]}, "product_type": "Drugs", "event_id": "95660", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0098-2025", "product_description": "Diltiazem Hydrochloride Extended-Release Capsules, USP 120mg, Twice-a-Day Dosage, Rx Only, 100 Capsules per bottle, Mfd for: Northstar Rx LLC, Memphis, TN, Mfd by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh India, NDC 16714-555-01.", "product_quantity": "7296 bottles", "reason_for_recall": "cGMP Deviations: Presence of N-nitroso-Desmethyl-Diltiazem impurity above FDA recommended interim limit.", "recall_initiation_date": "20241101", "center_classification_date": "20241203", "report_date": "20241211", "code_info": "Lot #:17222547, Exp. Date, 11/30/2024; 17230598, Exp. Date 02/28/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Shirley", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA021135"], "brand_name": ["VENOFER"], "generic_name": ["IRON SUCROSE"], "manufacturer_name": ["Fresenius Medical Care Holdings, Inc."], "product_ndc": ["49230-530", "49230-534"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["IRON SUCROSE"], "rxcui": ["1741267", "1741268", "1741270", "1741271"], "spl_id": ["e12cb876-ae80-416b-9bd3-a1cc83c9e666"], "spl_set_id": ["f1ab1a22-2b99-4d27-8b5a-9c3bcd5e3040"], "package_ndc": ["49230-530-01", "49230-530-10", "49230-530-25", "49230-534-01", "49230-534-10", "49230-534-25"], "is_original_packager": [true], "upc": ["0349230530254", "0349230534252"], "nui": ["M0011718", "N0000177913"], "pharm_class_cs": ["Iron [CS]"], "pharm_class_epc": ["Parenteral Iron Replacement [EPC]"], "unii": ["FZ7NYF5N8L"]}, "product_type": "Drugs", "event_id": "95711", "recalling_firm": "American Regent, Inc.", "address_1": "5 Ramsey Rd", "address_2": "", "postal_code": "11967-4701", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0081-2025", "product_description": "Venofer (iron sucrose) Injection, USP 50 mg Elemental Iron per 2.5 mL (20 mg/mL), 2.5 mL Single-Dose Vials, Rx Only, For Intravenous Use Only, Distributed by: Fresenius Medical Care NA, Waltham, MA 02451, NDC: 49230-530-01 (vial), NDC: 49230-530-10 (10 x 2.5mL/vial cartons), NDC: 49230-530-25 (25 x 2.5mL/vial cartons).", "product_quantity": "", "reason_for_recall": "Presence of Particulate Matter: Potential for glass delamination from the vials.", "recall_initiation_date": "20241111", "center_classification_date": "20241129", "report_date": "20241211", "code_info": "Lot #s: 4206, 4210, Exp 05/31/2026; 4223, Exp 06/30/2026; 24231, 24237, Exp 07/31/2026.", "more_code_info": ""}, {"status": "Ongoing", "city": "Gibbstown", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M022"], "brand_name": ["SAFCO SENSICAINE ULTRA TOPICAL ANESTHETIC GEL"], "generic_name": ["BENZOCAINE"], "manufacturer_name": ["Safco Dental Supply Co."], "product_ndc": ["67239-0219"], "product_type": ["HUMAN OTC DRUG"], "route": ["DENTAL"], "substance_name": ["BENZOCAINE"], "rxcui": ["238910"], "spl_id": ["2b3abb36-2cdc-b478-e063-6294a90a4f45"], "spl_set_id": ["9235cb3f-a45b-10e5-e053-2995a90ae5e3"], "package_ndc": ["67239-0219-1"], "is_original_packager": [true], "nui": ["N0000185508", "N0000175629", "N0000184306", "M0000728"], "pharm_class_epc": ["Standardized Chemical Allergen [EPC]"], "pharm_class_pe": ["Increased Histamine Release [PE]", "Cell-mediated Immunity [PE]"], "pharm_class_cs": ["Allergens [CS]"], "unii": ["U3RSY48JW5"]}, "product_type": "Drugs", "event_id": "95854", "recalling_firm": "Keystone Industries", "address_1": "480 S Democrat Rd", "address_2": "", "postal_code": "08027-1239", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the USA and Canada, Dominican Republic, El Salvador, Honduras, and Qatar.", "recall_number": "D-0145-2025", "product_description": "safco, SensiCaine Ultra, Topical Anesthetic Gel, Contains 20% Benzocaine, 1 oz (29.6 mL), Cherry, NDC 67239-0219-1, Gluten Free, Distributed by: Safco Dental Supply Co., Buffalo Grove, IL 60089, Made in USA, For Professional Use Only.", "product_quantity": "", "reason_for_recall": "CGMP deviations: the bulk product was rejected by the Quality Unit after routine inspection of the mixing vessel showed scratches on the sides and bottom of the mixing vessel. Product was to be rejected but was inadvertently released and shipped to customers.", "recall_initiation_date": "20241114", "center_classification_date": "20241213", "report_date": "20241225", "code_info": "Lot: BNZ-001646, Exp Date: 11/26/2026, Keystone Item No. 03-64119", "more_code_info": ""}, {"status": "Ongoing", "city": "Raleigh", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA206774"], "brand_name": ["CISPLATIN"], "generic_name": ["CISPLATIN"], "manufacturer_name": ["Accord Healthcare Inc."], "product_ndc": ["16729-288"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["CISPLATIN"], "rxcui": ["309311"], "spl_id": ["2860827e-1817-2b85-e063-6394a90a127e"], "spl_set_id": ["b2b029f5-0d7e-4e7f-accc-b722aec34c68"], "package_ndc": ["16729-288-11", "16729-288-38"], "is_original_packager": [true], "upc": ["0316729288385", "0316729288118"], "nui": ["N0000175413", "N0000175073"], "pharm_class_epc": ["Platinum-based Drug [EPC]"], "unii": ["Q20Q21Q62J"]}, "product_type": "Drugs", "event_id": "95455", "recalling_firm": "ACCORD HEALTHCARE, INC.", "address_1": "8041 Arco Corporate Dr Ste 200", "address_2": "", "postal_code": "27617-2010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States and PR", "recall_number": "D-0010-2025", "product_description": "Cisplatin Injection, 100mg/100mL (1mg/mL), For Intravenous Use, 100 mL Multiple Dose Vial, Rx Only, Manufactured for: Accord Healthcare Inc., Durham, NC 27703. Manufactured by: Intas Pharmaceuticals Limited, Pharmez, Ahmedabad 382 213, India. Mfg. Lic. No.: G/28/1336, NDC 16729-288-38", "product_quantity": "11,214 vials", "reason_for_recall": "Failed Impurities/Degradation Specifications.", "recall_initiation_date": "20241001", "center_classification_date": "20241011", "report_date": "20241023", "code_info": "Lot #: P2202009, Exp. Date: 03/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Pulaski", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95897", "recalling_firm": "AvKARE", "address_1": "615 N 1st St", "address_2": "", "postal_code": "38478-2403", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide", "recall_number": "D-0109-2025", "product_description": "Cinacalcet Tablets, 60 mg, 30-count bottle, Rx only, Manufactured for: AvKARE, Pulaski, TN 38478, NDC 42291-460-30", "product_quantity": "2,396 bottles", "reason_for_recall": "CGMP deviations: Presence of Nitrosamine Drug Substance Related Impurity (NDSRI), N-Nitroso-Cinacalcet above acceptable intake limit.", "recall_initiation_date": "20241127", "center_classification_date": "20241205", "report_date": "20241211", "code_info": "Lot # 44550, Exp 12/31/2024", "more_code_info": ""}, {"status": "Ongoing", "city": "Rockford", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA076187"], "brand_name": ["LEVOTHYROXINE SODIUM"], "generic_name": ["LEVOTHYROXINE SODIUM"], "manufacturer_name": ["Mylan Institutional Inc."], "product_ndc": ["42292-038", "42292-039", "42292-041", "42292-040"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LEVOTHYROXINE SODIUM"], "rxcui": ["966248", "966249", "966253", "966270"], "spl_id": ["3a991bf1-d9aa-b137-e063-6294a90af2cf"], "spl_set_id": ["cd69c192-cd3f-47e6-b0a6-c536ffed5c4b"], "package_ndc": ["42292-038-01", "42292-038-20", "42292-039-01", "42292-039-20", "42292-041-01", "42292-041-20", "42292-040-01", "42292-040-20"], "original_packager_product_ndc": ["0378-1807", "0378-1811", "0378-1823", "0378-1817"], "unii": ["9J765S329G"]}, "product_type": "Drugs", "event_id": "95817", "recalling_firm": "Mylan Institutional, Inc.", "address_1": "1718 Northrock Ct", "address_2": "", "postal_code": "61103-1201", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0132-2025", "product_description": "Levothyroxine Sodium Tablets, USP, 112 mcg (0.112 mg), 100 Tablets per carton (10 unit dose blister cards of 10 tablets each), Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 USA. NDC: 42292-039-20", "product_quantity": "988 cartons", "reason_for_recall": "Subpotent and Superpotent Drug", "recall_initiation_date": "20241119", "center_classification_date": "20241212", "report_date": "20241218", "code_info": "Lot #: 3115707, Exp. Date 02/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Athens", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95826", "recalling_firm": "Midlab Incorporated", "address_1": "140 Private Brand Way", "address_2": "", "postal_code": "37303-1401", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0089-2025", "product_description": "Array Liquid Antiseptic Handwash, Chloroxylenol 0.1%, NET CONTENTS: 128 FL OZ (1 GAL) 3.785 L, FOR DISTRIBUTION EXCLUSIVELY BY GORDON FOOD SERVICE, WYOMING, MI 49509", "product_quantity": "", "reason_for_recall": "cGMP Deviations: Out of specification results for micro in hand soap products.", "recall_initiation_date": "20241106", "center_classification_date": "20241202", "report_date": "20241211", "code_info": "Lot 0711241", "more_code_info": ""}, {"status": "Ongoing", "city": "Sacramento", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA213853"], "brand_name": ["ATORVASTATIN CALCIUM"], "generic_name": ["ATORVASTATIN CALCIUM"], "manufacturer_name": ["NIVAGEN PHARMACEUTICALS, INC."], "product_ndc": ["75834-255", "75834-256", "75834-257", "75834-258"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ATORVASTATIN"], "rxcui": ["259255", "617310", "617311", "617312"], "spl_id": ["301ed63e-05d1-077f-e063-6294a90a72ee"], "spl_set_id": ["7c58bf4a-4a92-4db8-89bc-4de1b5831efc"], "package_ndc": ["75834-256-90", "75834-256-01", "75834-256-05", "75834-256-50", "75834-255-90", "75834-255-01", "75834-255-05", "75834-255-50", "75834-257-90", "75834-257-50", "75834-257-25", "75834-257-01", "75834-258-90", "75834-258-50", "75834-258-02", "75834-258-01"], "is_original_packager": [true], "upc": ["0375834258027", "0375834257501", "0375834255903", "0375834256016"], "nui": ["N0000175589", "N0000000121"], "pharm_class_epc": ["HMG-CoA Reductase Inhibitor [EPC]"], "pharm_class_moa": ["Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]"], "unii": ["A0JWA85V8F"]}, "product_type": "Drugs", "event_id": "95418", "recalling_firm": "Nivagen Pharmaceuticals Inc", "address_1": "3100 Fite Cir", "address_2": "N/A", "postal_code": "95827-1805", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide within the U.S", "recall_number": "D-0001-2025", "product_description": "Atorvastatin Calcium Tablets, USP, 40mg, Rx only, 1000 Tablets per bottle, Manufactured for: Nivagen Pharmaceuticals, Inc. Sacramento, CA 95827, USA, Manufactured by: Umedica Laboratories Pvt Ltd., Vapi Gujarat 396195, India, NDC: 75834-257-01.", "product_quantity": "2328 bottles", "reason_for_recall": "Presence of Foreign Tablets/Capsules: A Carbamazepine Extended-Release 400 mg tablet was found in a 1000-count bottle of Atorvastatin Calcium Tablets, USP 40 mg.", "recall_initiation_date": "20240924", "center_classification_date": "20241002", "report_date": "20241009", "code_info": "Lot #: U24T0408A, Exp: 03/31/2026"}, {"status": "Ongoing", "city": "Gibbstown", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95854", "recalling_firm": "Keystone Industries", "address_1": "480 S Democrat Rd", "address_2": "", "postal_code": "08027-1239", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the USA and Canada, Dominican Republic, El Salvador, Honduras, and Qatar.", "recall_number": "D-0140-2025", "product_description": "Dental City, Topical Anesthetic Gel, Benzocaine 20%, Net Content: 1 oz. (30 ml), Gluten Free, Manufactured for: Dental City, Green Bay, WI 54311, dentalcity.com.", "product_quantity": "", "reason_for_recall": "CGMP deviations: the bulk product was rejected by the Quality Unit after routine inspection of the mixing vessel showed scratches on the sides and bottom of the mixing vessel. Product was to be rejected but was inadvertently released and shipped to customers.", "recall_initiation_date": "20241114", "center_classification_date": "20241213", "report_date": "20241225", "code_info": "Lot: BNZ-001646, Exp Date: 11/26/2026, Keystone Item No. 03-25119", "more_code_info": ""}, {"status": "Terminated", "city": "Hauppauge", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M012"], "brand_name": ["SEVERE COLD AND FLU PLUS CONGESTION"], "generic_name": ["ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE, GUAIFENESIN, PHENYLEPHRINE HCL"], "manufacturer_name": ["COSTCO WHOLESALE CORPORATION"], "product_ndc": ["63981-795"], "product_type": ["HUMAN OTC DRUG"], "rxcui": ["1110988", "1546881", "2634817"], "spl_id": ["7eeaf644-7af4-48aa-bebd-20affe8d1323"], "spl_set_id": ["5180abbc-c6c4-4b82-b6e7-4504e3bcff0f"], "package_ndc": ["63981-795-81"], "is_original_packager": [true]}, "product_type": "Drugs", "event_id": "95773", "recalling_firm": "LNK International, Inc.", "address_1": "22 Arkay Dr", "address_2": "", "postal_code": "11788-3708", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to 1 wholesale retail customer who may have further distribute the product nationwide.", "recall_number": "D-0115-2025", "product_description": "Kirkland Severe Cold & Flu Plus Congestion: Day - 112 coated caplets blister pack; (Acetaminophen 325mg, Dextromethorphan HBr 10 mg, Guaifenesin 200 mg, Phenylephrine HCl 5 mg); Night - 56 coated caplets blister pack; (Acetaminophen 325mg, Dextromethorphan HBr 10 mg, Doxylamine succinate 6.25 mg, Phenylephrine HCl 5 mg); Manufactured BY: LNK International, Inc. FOR: Costco Wholesale Corporation. NDC# 63981-795-81", "product_quantity": "288 cases x 30  8,640 boxes", "reason_for_recall": "CGMP Deviations: Released product should have been rejected.", "recall_initiation_date": "20241114", "center_classification_date": "20241209", "termination_date": "20250902", "report_date": "20241218", "code_info": "Lot # P139953, exp. date 2026/AUG Lot # P139815, exp. date 2026/AUG", "more_code_info": ""}, {"status": "Ongoing", "city": "Woburn", "state": "MA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M343"], "brand_name": ["ASPIRIN"], "generic_name": ["ASPIRIN 81 MG"], "manufacturer_name": ["Safecor Health, LLC"], "product_ndc": ["48433-129"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["ASPIRIN"], "rxcui": ["318272"], "spl_id": ["2a9cbf5e-9081-4b19-bd60-5ddf103a0133"], "spl_set_id": ["b499f378-db7c-464e-bee3-eb23f8fdaced"], "package_ndc": ["48433-129-01"], "original_packager_product_ndc": ["69168-288"], "nui": ["N0000000160", "N0000008836", "M0001335", "N0000175722", "N0000175578", "N0000008832"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "pharm_class_pe": ["Decreased Prostaglandin Production [PE]", "Decreased Platelet Aggregation [PE]"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]"], "unii": ["R16CO5Y76E"]}, "product_type": "Drugs", "event_id": "95659", "recalling_firm": "Safecor Health, LLC", "address_1": "317 New Boston St", "address_2": "N/A", "postal_code": "01801-6231", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-0058-2025", "product_description": "Aspirin Chewable tablet 81 mg, 1 tablet in blister card-foils, 100-count unit dose box, www.safecorhealth.com, NDC 48433-129-01", "product_quantity": "1470 boxes", "reason_for_recall": "cGMP Deviations: Observations were made that some blister card-foils were separating from the blister cavity.", "recall_initiation_date": "20241111", "center_classification_date": "20241119", "report_date": "20241127", "code_info": "Lot# 24A0061, exp. date 05/23/2026"}, {"status": "Terminated", "city": "New Delhi", "state": "", "country": "India", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95595", "recalling_firm": "Unexo Life Sciences Private Limited", "address_1": "B16, Sector 4, Bawana Industrial Area", "address_2": "", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0069-2025", "product_description": "LILAS Feminine Pain Relief Patch, Menthol 10%, a) 5 patches per box (UPC 7 87099 48212 1) and 10 patches per box (UPC 7 87099 48211 4), Distributed by: Lilas Wellness, Inc., Beaverton, Oregon 97008-7105", "product_quantity": "363,300 patches", "reason_for_recall": "cGMP Deviations", "recall_initiation_date": "20241024", "center_classification_date": "20241122", "termination_date": "20250916", "report_date": "20241204", "code_info": "a) UPC 7 87099 48212 1 b) UPC 7 87099 48211 4", "more_code_info": ""}, {"status": "Ongoing", "city": "Canonsburg", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA076187"], "brand_name": ["LEVOTHYROXINE SODIUM"], "generic_name": ["LEVOTHYROXINE SODIUM"], "manufacturer_name": ["Mylan Pharmaceuticals Inc."], "product_ndc": ["0378-1800", "0378-1803", "0378-1805", "0378-1807", "0378-1809", "0378-1811", "0378-1813", "0378-1823", "0378-1815", "0378-1817", "0378-1819", "0378-1821"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LEVOTHYROXINE SODIUM"], "rxcui": ["892246", "892251", "892255", "966220", "966221", "966222", "966224", "966225", "966248", "966249", "966253", "966270"], "spl_id": ["ca193039-55b1-4a7e-aa67-c4bff4f9f5b0"], "spl_set_id": ["e95720f2-91c9-a6d0-f7d5-8bcb94d07bbc"], "package_ndc": ["0378-1800-77", "0378-1800-10", "0378-1803-77", "0378-1803-10", "0378-1805-77", "0378-1805-10", "0378-1807-77", "0378-1807-10", "0378-1809-77", "0378-1809-10", "0378-1811-77", "0378-1811-10", "0378-1813-77", "0378-1813-10", "0378-1823-77", "0378-1823-10", "0378-1815-77", "0378-1815-10", "0378-1817-77", "0378-1817-10", "0378-1819-77", "0378-1819-10", "0378-1821-77"], "is_original_packager": [true], "unii": ["9J765S329G"]}, "product_type": "Drugs", "event_id": "95768", "recalling_firm": "Viatris Inc", "address_1": "1000 Mylan Blvd", "address_2": "", "postal_code": "15317-5853", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States and Puerto Rico", "recall_number": "D-0118-2025", "product_description": "Levothyroxine Sodium Tablets USP, 125 mcg, packaged in a) 90-count bottles (NDC 0378-1813-77) and b) 1000-count bottles (NDC 0378-1813-10), Rx only, Manufactured for: Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A.", "product_quantity": "92,512 bottles", "reason_for_recall": "Superpotent Drug and Subpotent Drug: potency failures obtained", "recall_initiation_date": "20241118", "center_classification_date": "20241212", "report_date": "20241218", "code_info": "Lot #: a) 3182797, Exp. Date Nov 2024; 8177587, b) 3199816, Exp. Date  Jun 2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Aurangabad, Maharashtra State", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {"application_number": ["ANDA077259"], "brand_name": ["TIMOLOL MALEATE"], "generic_name": ["TIMOLOL MALEATE"], "manufacturer_name": ["Rising Pharma Holdings, Inc."], "product_ndc": ["64980-513", "64980-514"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["OPHTHALMIC"], "substance_name": ["TIMOLOL MALEATE"], "rxcui": ["1923428", "1992303"], "spl_id": ["7ef88352-6fe4-48a4-b72b-15419d3ed051"], "spl_set_id": ["2ed21930-1e05-46de-8acd-cb6f4798a7fa"], "package_ndc": ["64980-513-05", "64980-513-01", "64980-513-15", "64980-514-05", "64980-514-01", "64980-514-15"], "is_original_packager": [true], "upc": ["0364980513050", "0364980514057"], "unii": ["P8Y54F701R"]}, "product_type": "Drugs", "event_id": "95648", "recalling_firm": "FDC Limited", "address_1": "B-8 MIDC Industrial Area", "address_2": "Waluj District", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed to one Us Distributor in NJ.", "recall_number": "D-0035-2025", "product_description": "Timolol Maleate Ophthalmic Solution USP, 0.5%, Sterile, 5mL bottles, Rx only, Manufactured by: FDC Limited, Waluj, Aurangabad, Maharashtra, India, Distributed by: Rising Pharmaceuticals Inc, New Jersey, NDC 64980-514-05.", "product_quantity": "155,232 bottles", "reason_for_recall": "Defective Container: Unable to get the solution out of the bottle as the spike of the cap was lodged in the nozzle of the product bottle", "recall_initiation_date": "20241029", "center_classification_date": "20241101", "report_date": "20241113", "code_info": "Lot #: 083L051, Exp. Date: 11/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Gibbstown", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M022"], "brand_name": ["HEALTH-TEC TOPICAL ANESTHETIC"], "generic_name": ["BENZOCAINE"], "manufacturer_name": ["Dental Health Products, Inc."], "product_ndc": ["69634-021"], "product_type": ["HUMAN OTC DRUG"], "route": ["DENTAL"], "substance_name": ["BENZOCAINE"], "rxcui": ["238910"], "spl_id": ["2b39dbc0-2d0d-0a7f-e063-6394a90add31"], "spl_set_id": ["170ce528-7115-463c-b360-1d7a958bbd81"], "package_ndc": ["69634-021-30"], "is_original_packager": [true], "nui": ["N0000185508", "N0000175629", "N0000184306", "M0000728"], "pharm_class_epc": ["Standardized Chemical Allergen [EPC]"], "pharm_class_pe": ["Increased Histamine Release [PE]", "Cell-mediated Immunity [PE]"], "pharm_class_cs": ["Allergens [CS]"], "unii": ["U3RSY48JW5"]}, "product_type": "Drugs", "event_id": "95854", "recalling_firm": "Keystone Industries", "address_1": "480 S Democrat Rd", "address_2": "", "postal_code": "08027-1239", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the USA and Canada, Dominican Republic, El Salvador, Honduras, and Qatar.", "recall_number": "D-0142-2025", "product_description": "Health-Tec, Topical Anesthetic Gel, Benzocaine 20%, Made in USA, 1 FL. OZ (29.6 ml), NDC 69634-021-30.", "product_quantity": "", "reason_for_recall": "CGMP deviations: the bulk product was rejected by the Quality Unit after routine inspection of the mixing vessel showed scratches on the sides and bottom of the mixing vessel. Product was to be rejected but was inadvertently released and shipped to customers.", "recall_initiation_date": "20241114", "center_classification_date": "20241213", "report_date": "20241225", "code_info": "Lot: BNZ-001646, Exp Date: 11/26/2026, Keystone Item No. 03-28119", "more_code_info": ""}, {"status": "Terminated", "city": "Canton", "state": "MA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95427", "recalling_firm": "Fresenius Kabi Compounding, LLC", "address_1": "20 Dan Rd", "address_2": "N/A", "postal_code": "02021-2809", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to 125 direct accounts nationwide.", "recall_number": "D-0016-2025", "product_description": "Phenylephrine HCl 0.9% Sodium Chloride Injection USP, 10 mg per 250 mL, Single Dose Bag, Rx only, Fagron Sterile Services, Canton, MA NDC 71506-010-58", "product_quantity": "2756 bags", "reason_for_recall": "cGMP violations", "recall_initiation_date": "20240925", "center_classification_date": "20241021", "termination_date": "20250815", "report_date": "20241030", "code_info": "Lot #C274-000037039, exp. date 9-Oct-24 C274-000037239, exp. date 21-Oct-24", "more_code_info": ""}, {"status": "Ongoing", "city": "Sacramento", "state": "CA", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "95714", "recalling_firm": "Boulla LLC", "address_1": "2108 N ST #7929", "address_2": "", "postal_code": "95816", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0086-2025", "product_description": "ZapMax Capsules, 500 mg, 10 count blisters in cartons, Distributed by: ZapMax, 2108 N St. Sacramento, CA 95816, www.zapmax.com", "product_quantity": "Unknown", "reason_for_recall": "Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and diclofenac.", "recall_initiation_date": "20241104", "center_classification_date": "20241202", "report_date": "20241211", "code_info": "Lot #: YZM240406, Exp: 04/05/2027", "more_code_info": ""}, {"status": "Ongoing", "city": "Gibbstown", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95854", "recalling_firm": "Keystone Industries", "address_1": "480 S Democrat Rd", "address_2": "", "postal_code": "08027-1239", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the USA and Canada, Dominican Republic, El Salvador, Honduras, and Qatar.", "recall_number": "D-0139-2025", "product_description": "Primo, Topical Anesthetic gel, Benzocaine 20%, Net Content: 1 oz. (30g), Gluten Free, Manufactured for: Primo Dental Products, 845 Third Avenue, 6th Floor, New York, NY 10022.", "product_quantity": "", "reason_for_recall": "CGMP deviations: the bulk product was rejected by the Quality Unit after routine inspection of the mixing vessel showed scratches on the sides and bottom of the mixing vessel. Product was to be rejected but was inadvertently released and shipped to customers.", "recall_initiation_date": "20241114", "center_classification_date": "20241213", "report_date": "20241225", "code_info": "Lot: BNZ-001646, Exp Date: 11/26/2026, Keystone Item No. 03-13119", "more_code_info": ""}, {"status": "Ongoing", "city": "Canonsburg", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA076187"], "brand_name": ["LEVOTHYROXINE SODIUM"], "generic_name": ["LEVOTHYROXINE SODIUM"], "manufacturer_name": ["Mylan Pharmaceuticals Inc."], "product_ndc": ["0378-1800", "0378-1803", "0378-1805", "0378-1807", "0378-1809", "0378-1811", "0378-1813", "0378-1823", "0378-1815", "0378-1817", "0378-1819", "0378-1821"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LEVOTHYROXINE SODIUM"], "rxcui": ["892246", "892251", "892255", "966220", "966221", "966222", "966224", "966225", "966248", "966249", "966253", "966270"], "spl_id": ["ca193039-55b1-4a7e-aa67-c4bff4f9f5b0"], "spl_set_id": ["e95720f2-91c9-a6d0-f7d5-8bcb94d07bbc"], "package_ndc": ["0378-1800-77", "0378-1800-10", "0378-1803-77", "0378-1803-10", "0378-1805-77", "0378-1805-10", "0378-1807-77", "0378-1807-10", "0378-1809-77", "0378-1809-10", "0378-1811-77", "0378-1811-10", "0378-1813-77", "0378-1813-10", "0378-1823-77", "0378-1823-10", "0378-1815-77", "0378-1815-10", "0378-1817-77", "0378-1817-10", "0378-1819-77", "0378-1819-10", "0378-1821-77"], "is_original_packager": [true], "unii": ["9J765S329G"]}, "product_type": "Drugs", "event_id": "95768", "recalling_firm": "Viatris Inc", "address_1": "1000 Mylan Blvd", "address_2": "", "postal_code": "15317-5853", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States and Puerto Rico", "recall_number": "D-0122-2025", "product_description": "Levothyroxine Sodium Tablets USP, 200 mcg, packaged in a) 90-count bottles (NDC 0378-1819-77) and b) 1000-count bottles (NDC 0378-1819-10), Rx only, Manufactured for: Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A.", "product_quantity": "55,032 bottles", "reason_for_recall": "Superpotent Drug and Subpotent Drug: potency failures obtained", "recall_initiation_date": "20241118", "center_classification_date": "20241212", "report_date": "20241218", "code_info": "Lot #: a)8179847, Exp. Date July 2025; b) 3203518, Exp. Date July 2025", "more_code_info": ""}, {"status": "Terminated", "city": "Canton", "state": "MA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95427", "recalling_firm": "Fresenius Kabi Compounding, LLC", "address_1": "20 Dan Rd", "address_2": "N/A", "postal_code": "02021-2809", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to 125 direct accounts nationwide.", "recall_number": "D-0022-2025", "product_description": "EPINEPHrine 0.9% Sodium Chloride Injection USP, 8 mg per 250 mL Single Dose Bag, Rx only, Fagron Sterile Services, Canton, MA NDC: 71506-060-58", "product_quantity": "753 bags", "reason_for_recall": "cGMP violations", "recall_initiation_date": "20240925", "center_classification_date": "20241021", "termination_date": "20250815", "report_date": "20241030", "code_info": "Lot # C274-000038958, exp. date 17-Oct-24 C274-000039206, exp. date 23-Oct-24", "more_code_info": ""}, {"status": "Ongoing", "city": "Rockford", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA076187"], "brand_name": ["LEVOTHYROXINE SODIUM"], "generic_name": ["LEVOTHYROXINE SODIUM"], "manufacturer_name": ["Mylan Institutional Inc."], "product_ndc": ["42292-038", "42292-039", "42292-041", "42292-040"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LEVOTHYROXINE SODIUM"], "rxcui": ["966248", "966249", "966253", "966270"], "spl_id": ["3a991bf1-d9aa-b137-e063-6294a90af2cf"], "spl_set_id": ["cd69c192-cd3f-47e6-b0a6-c536ffed5c4b"], "package_ndc": ["42292-038-01", "42292-038-20", "42292-039-01", "42292-039-20", "42292-041-01", "42292-041-20", "42292-040-01", "42292-040-20"], "original_packager_product_ndc": ["0378-1807", "0378-1811", "0378-1823", "0378-1817"], "unii": ["9J765S329G"]}, "product_type": "Drugs", "event_id": "95817", "recalling_firm": "Mylan Institutional, Inc.", "address_1": "1718 Northrock Ct", "address_2": "", "postal_code": "61103-1201", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0134-2025", "product_description": "Levothyroxine Sodium Tablets, USP, 137 mcg (0.137 mg), 100 Tablets per carton (10 unit dose blister cards of 10 tablets each), Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 USA.  NDC: 42292-041-20", "product_quantity": "1,133 cartons", "reason_for_recall": "Subpotent and Superpotent Drug", "recall_initiation_date": "20241119", "center_classification_date": "20241212", "report_date": "20241218", "code_info": "Lot #: 3115448, Exp. Date 12/31/2024;3115732, Exp. Date  3/31/2025;  3116024, Exp. Date 9/30/2025", "more_code_info": ""}, {"status": "Terminated", "city": "Canton", "state": "MA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95427", "recalling_firm": "Fresenius Kabi Compounding, LLC", "address_1": "20 Dan Rd", "address_2": "N/A", "postal_code": "02021-2809", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to 125 direct accounts nationwide.", "recall_number": "D-0021-2025", "product_description": "Oxytocin 0.9% Sodium Chloride Injection USP, 30 units per 500 mL Single Dose Bag, Rx only, Fagron Sterile Services, Canton, MA NDC: 71506-028-59", "product_quantity": "4436 bags", "reason_for_recall": "cGMP violations", "recall_initiation_date": "20240925", "center_classification_date": "20241021", "termination_date": "20250815", "report_date": "20241030", "code_info": "Lot # C274-000038801, exp. date 9-Oct-24 C274-000039045, exp. date 24-Oct-24 C274-000039240, exp. date 31-Oct-24", "more_code_info": ""}, {"status": "Ongoing", "city": "Lexington", "state": "KY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95823", "recalling_firm": "Neogen Corporation", "address_1": "1847 Mercer Rd Ste A", "address_2": "", "postal_code": "40511-1001", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product sold directly to one distributor consignee, Bob Barker Company, an American company that sells supplies to prisons, jails, and other institutions.", "recall_number": "D-0073-2025", "product_description": "LICEOUT, Liquid Lice Treatment for Human Use, Contents: 1 FL. OZ. (29.6 mL) per sachet, Distributed By: Bob Barker Company, Inc., 7925 Purfoy Road, Fuquay-Varina, NC 27526.  NDC: 53427-124-01", "product_quantity": "5,328 sachets", "reason_for_recall": "CGMP violations.", "recall_initiation_date": "20241008", "center_classification_date": "20241127", "report_date": "20241204", "code_info": "Lot LO09530; Exp 9/5/2025", "more_code_info": ""}, {"status": "Terminated", "city": "Palm Harbor", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M018"], "brand_name": ["REGENER-EYES"], "generic_name": ["GLYCERIN"], "manufacturer_name": ["Regenerative Processing Plant, LLC"], "product_ndc": ["82305-006"], "product_type": ["HUMAN OTC DRUG"], "route": ["OPHTHALMIC"], "substance_name": ["GLYCERIN"], "rxcui": ["2610311", "2610313"], "spl_id": ["30caa73a-ed9b-753f-e063-6394a90add63"], "spl_set_id": ["e7796d0d-13d7-73c3-e053-2995a90a8bde"], "package_ndc": ["82305-006-01", "82305-006-02"], "is_original_packager": [true], "nui": ["N0000185370", "N0000175629", "N0000184306", "N0000185001", "M0000728", "M0009417"], "pharm_class_epc": ["Non-Standardized Chemical Allergen [EPC]"], "pharm_class_pe": ["Increased Histamine Release [PE]", "Cell-mediated Immunity [PE]", "Increased IgG Production [PE]"], "pharm_class_cs": ["Allergens [CS]", "Glycerol [CS]"], "unii": ["PDC6A3C0OX"]}, "product_type": "Drugs", "event_id": "95912", "recalling_firm": "Regenerative Processing Plant, LLC", "address_1": "34176 Us Highway 19 N", "address_2": "", "postal_code": "34684-2144", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0152-2025", "product_description": "LITE Regener-Eyes, Ophthalmic Solution (glycerin 0.4%), 3mL bottles, Distributed by: Regener-Eyes, Tampa, FL; Manufactured by: Regenerative Processing Plant, LLC, 34176 US HWY 19N, FL, NDC 82305-006-01", "product_quantity": "170812 bottles", "reason_for_recall": "Lack of Sterility Assurance", "recall_initiation_date": "20241210", "center_classification_date": "20241217", "termination_date": "20250627", "report_date": "20241225", "code_info": "Lot #:  P121322A, P121322B, Exp. Date 12/13/2024; P121422A, Exp. Date 12/14/2024; P121922A, P121922B, Exp. Date 12/19/2024; P122022A, Exp. Date 12/20/2024; P122122A, P122122B, Exp. Date 12/21/2024; P122622A, P122622B, Exp. Date 12/26/2024; P122722A, P122722B, Exp. Date 12/27/2024; P122822A, P122822B, Exp. Date 12/28/2024. P010223A, Exp. Date 1/2/2025; P010323LV1, Exp. Date 1/3/2025; P010523A, P010523B, Exp. Date 1/5/2025; P010923A, Exp. Date 1/9/2025; P011023LV2, Exp. Date 1/10/2025, P011223A, P011223B, Exp. Date 1/12/2025; P011623A; Exp. Date 1/16/2025, P011723LV3, Exp. Date 1/17/2025; P011923A, P011923B, Exp. Date 1/19/2025; P012323A, P012323B, Exp. Date 1/23/2025; P012523A, Exp. Date 1/25/2025; P013123A, Exp. Date 1/31/2025; P020223A, Exp. Date 2/2/2025; P020623A, Exp. Date 2/6/2025,P020823A, Exp. Date 2/8/2025, P020923A, Exp. Date 2/9/2025, P021323A, Exp. Date 2/13/2025;  P021523A, P021523B, Exp. Date  2/15/2025, P021623A, Exp. Date 2/16/2025, P022023A, Exp. Date 2/20/2025, P022123A, Exp. Date 2/21/2025, P022323A, Exp. Date 2/23/2025, P022723A, Exp. Date 2/27/2025, P030123A, Exp. Date 3/1/2025, P030223A, Exp. Date 3/2/2025, P030623A, Exp. Date 3/6/2025; P030723A, Exp. Date 3/7/2025; P030823A, Exp. Date 3/8/2025; P030923A Exp. Date 3/9/2025, P031423A, Exp. Date 3/14/2025, P032023A, Exp. Date 3/20/2025, P032123A, Exp. Date 3/21/2025; P032223A, Exp. Date 3/22/2025; P032723A, Exp. Date 3/27/2025; P040423A, Exp. Date 4/4/2025; P040523A, Exp. Date 4/5/2025; P040623A, Exp. Date 4/6/2025; P041023A, Exp. Date 4/10/2025;P041123A, Exp. Date 4/11/2025; P041223A, Exp. Date 4/12/2025; P041323A, Exp. Date 4/13/2025; P041723A, Exp. Date 4/17/2025; P041823A, Exp. Date 4/18/2025;P041923A, Exp. Date 4/19/2025; P042023A, Exp. Date 4/20/2025; P042423A, Exp. Date 4/24/2025; P042523A, Exp. Date 4/25/2025;P042623A, Exp. Date 4/26/2025; P050323A, Exp. Date 5/3/2025; P050823A, Exp. Date 5/8/2025;P050923A, Exp. Date 5/9/2025;P051023A, Exp. Date 5/10/2025;P051123A, Exp. Date 5/11/2025;P051523A, Exp. Date 5/15/2025; P051623A, Exp. Date 5/16/2025; P051723A, Exp. Date 5/17/2025; P052223A, Exp.: 5/22/2025; P052323A, Exp.: 5/23/2025; P052423A, Exp. Date 5/24/2025; P052523A, Exp.: 5/25/2025; P053023A, Exp. Date 5/30/2025; P053123A, Exp. Date 5/31/2025; P060123A, Exp. Date 6/1/2025; P060223A, Exp. Date 6/2/2025; P060523A, Exp. Date 6/5/2025; P060623A, Exp. Date 6/6/2025; P060723A, Exp. Date 6/7/2025; P060823A, Exp. Date 6/8/2025; P061223A, Exp. Date 6/12/2025; P061323A, Exp. Date 6/13/2025; P061423A, Exp. Date 6/14/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Millburn", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95420", "recalling_firm": "Advanced Accelerator Applications USA, Inc.", "address_1": "57 E Willow St", "address_2": "N/A", "postal_code": "07041-1416", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, MA, NJ, NY, PA, and VA", "recall_number": "D-0007-2025", "product_description": "Pluvicto, 1000 MBq/mL (27 mCi/mL), lutetium, LU 177, vipivotide tetraxetan injection, Single-dose vial, Sterile, Manufacturer Advanced Accelerator Applications,  57 E. Willow Street, NJ 07041, Millburn USA. NDC 69488-0010-61", "product_quantity": "99 doses", "reason_for_recall": "CGMP deviations", "recall_initiation_date": "20240923", "center_classification_date": "20241003", "report_date": "20241009", "code_info": "Lot#: LPS240919B-16, 24-Sep-2024 Lot#: LPS240920B-16, 25-Sep-2024  Lot#: LPS240920C-16, 25-Sep-2024"}, {"status": "Terminated", "city": "Seymour", "state": "IN", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA215802"], "brand_name": ["LISDEXAMFETAMINE DIMESYLATE"], "generic_name": ["LISDEXAMFETAMINE DIMESYLATE"], "manufacturer_name": ["Lannett Company, Inc."], "product_ndc": ["0527-4661", "0527-4662", "0527-4663", "0527-4664", "0527-4665", "0527-4666", "0527-4667"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LISDEXAMFETAMINE DIMESYLATE"], "rxcui": ["854830", "854834", "854838", "854842", "854846", "854850", "1593856"], "spl_id": ["7ac942a6-689a-420b-87bf-dc59003400dc"], "spl_set_id": ["2cedb4c2-1e40-4bc4-b9f4-127150c4afbd"], "package_ndc": ["0527-4661-37", "0527-4662-37", "0527-4663-37", "0527-4664-37", "0527-4665-37", "0527-4666-37", "0527-4667-37"], "is_original_packager": [true], "upc": ["0305274664379", "0305274666373", "0305274661378", "0305274665376", "0305274667370", "0305274663372"], "unii": ["SJT761GEGS"]}, "product_type": "Drugs", "event_id": "95630", "recalling_firm": "Lannett Company Inc.", "address_1": "1101 C Ave W", "address_2": "", "postal_code": "47274-3342", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0112-2025", "product_description": "Lisdexamfetamine Dimesylate Capsules, 10 mg, 100 Capsules per bottle, Rx only, Distributed by: Lannet Company, Philadelphia, PA 19136, NDC:  0527-4661-37", "product_quantity": "1608 bottles", "reason_for_recall": "Failed Content Uniformity Specifications: Product failed to meet the action limits for stratified content uniformity.", "recall_initiation_date": "20241025", "center_classification_date": "20241205", "termination_date": "20250627", "report_date": "20241211", "code_info": "Lot: 23274856A, Exp 04/30/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Fresno", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95819", "recalling_firm": "Generitech Corporation", "address_1": "4967 E Lansing Way", "address_2": "", "postal_code": "93727-7408", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "CA", "recall_number": "D-0111-2025", "product_description": "10 Irregular Pigmentation, Accelerator, Pigment Fading Activator, Only Your Rx, Nature + Science, 1 fl. oz., 30 mL Bottle, For Professional Use Only, Only YourRx Inc., Chatsworth, CA 91311, Made in USA, Onlyyourrx.com.", "product_quantity": "77.5lbs", "reason_for_recall": "CGMP Deviations: Inconsistency in the water systems.", "recall_initiation_date": "20241122", "center_classification_date": "20241205", "report_date": "20241211", "code_info": "Lot #: 2400017, Exp: 4/30/2026", "more_code_info": ""}, {"status": "Ongoing", "city": "Dawsonville", "state": "GA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95618", "recalling_firm": "Direct Rx", "address_1": "94 Worldwide Dr", "address_2": "N/A", "postal_code": "30534-6828", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0041-2025", "product_description": "Ibuprofen 800mg, Generic for: Motrin, Each tablet contains: Ibuprofen, USP 800 mg,  Packaged and Distributed by: DIRECT Rx, Dawsonville, GA 30534, Mfg By: Dr. Reddy's Laboratories LA, LLC, Shreveport, LA 71106, a) NDC 61919-0621-15 (15 count bottles), b) NDC 61919-0621-30 (30 count bottles, c) NDC 61919-0621-40 (40 count bottles), d) NDC 61919-0621-60 (60 count bottles), e) NDC 61919-0621-90 (90 count bottles), f) NDC: 61919-0621-100 and NDC: 61919-0621-71 (100 count bottles), g) NDC 61919-0621-72 (120 count bottles).", "product_quantity": "1410 bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications: Product failed impurity specifications at the 18-month stability testing.", "recall_initiation_date": "20240809", "center_classification_date": "20241107", "report_date": "20241113", "code_info": "Lot #s:   a) 02FE2414, Exp 11/30/26. b) 18JU2407, Exp 11/30/26; 27JY2316, Exp 02/28/27; 13SE2317, 13OC2312, 23AU2307, Exp 03/31/27. c) 25SE2308, Exp 03/31/27. d) 29MA2313, 23MA2315, Exp 12/31/26; 25MY2304, Exp 01/31/27; 26JU2313, 27JY2314,   Exp 02/28/27. e) 27SE2322, 30OC2304, 12OC2301, Exp 03/31/27. f)  11SE2322, 02FE2419, 23JA2405, 10JA2426, 17MY2416, 05DE2312, 24OC2321, 05FE2433, 20MA2418, 29NO2317, Exp 11/30/26. g) 31MA2308, Exp 12/31/26; 25SE2305, Exp 03/31/27.", "more_code_info": ""}, {"status": "Ongoing", "city": "Woburn", "state": "MA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M331"], "brand_name": ["CALCIUM ANTACID"], "generic_name": ["CALCIUM CARBONATE"], "manufacturer_name": ["Safecor Health, LLC"], "product_ndc": ["48433-106"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["CALCIUM CARBONATE"], "rxcui": ["308907"], "spl_id": ["3fff7c3b-5bc5-4cd6-bb28-29c72ac34a70"], "spl_set_id": ["636a00a9-9df5-40cb-940a-61cc52016a1b"], "package_ndc": ["48433-106-01"], "original_packager_product_ndc": ["69168-219"], "unii": ["H0G9379FGK"]}, "product_type": "Drugs", "event_id": "95659", "recalling_firm": "Safecor Health, LLC", "address_1": "317 New Boston St", "address_2": "N/A", "postal_code": "01801-6231", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-0059-2025", "product_description": "Calcium Carbonate Chewable 500 mg, 1 tablet in blister card-foils, 100-count unit dose box, www.safecorhealth.com, NDC 48433-106-01", "product_quantity": "791 boxes", "reason_for_recall": "cGMP Deviations: Observations were made that some blister card-foils were separating from the blister cavity.", "recall_initiation_date": "20241111", "center_classification_date": "20241119", "report_date": "20241127", "code_info": "Lot# 24A0073, exp. date 06/28/2026"}, {"status": "Ongoing", "city": "Raleigh", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA211892"], "brand_name": ["CINACALCET"], "generic_name": ["CINACALCET"], "manufacturer_name": ["Accord Healthcare, Inc."], "product_ndc": ["16729-440", "16729-441", "16729-442"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CINACALCET HYDROCHLORIDE"], "rxcui": ["432400", "432401", "432402"], "spl_id": ["40aa0834-3fd8-c230-e063-6294a90a800d"], "spl_set_id": ["6bad4e06-c0a1-4123-83c2-67d3b081e8a9"], "package_ndc": ["16729-440-10", "16729-440-15", "16729-440-01", "16729-441-10", "16729-441-15", "16729-441-01", "16729-442-10", "16729-442-15", "16729-442-01"], "is_original_packager": [true], "unii": ["1K860WSG25"]}, "product_type": "Drugs", "event_id": "95501", "recalling_firm": "ACCORD HEALTHCARE, INC.", "address_1": "8041 Arco Corporate Dr Ste 200", "address_2": "N/A", "postal_code": "27617-2010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and PR", "recall_number": "D-0032-2025", "product_description": "Cinacalcet Tablets, 90 mg, Rx Only, a) 30 Tablets per bottle, NDC: 16729-442-10, b) 90 Tablets per bottle, NDC: 16729-442-15, Manufactured for: Accord Healthcare, Inc., Durham, NC 27703. Manufactured by: Intas Pharmaceuticals Limited, Ahmedabad - 382 210, INDIA.", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: the presence of a nitrosamine impurity, N-nitroso-cinacalcet, above the acceptable daily intake (ADI) limits.", "recall_initiation_date": "20241010", "center_classification_date": "20241031", "report_date": "20241106", "code_info": "a) Lot #:              Expiry Date: M2303264            01/2026  b) Lot #:             Expiry Date: M2306979           04/2026", "more_code_info": ""}, {"status": "Ongoing", "city": "Sacramento", "state": "CA", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "95714", "recalling_firm": "Boulla LLC", "address_1": "2108 N ST #7929", "address_2": "", "postal_code": "95816", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0083-2025", "product_description": "VitalityXtra Capsules, 500 mg, packaged in 10 count blisters in cartons, Distributed by: VitalityXtra, San Francisco, CA www.vitalityxtra.com", "product_quantity": "Unknown", "reason_for_recall": "Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and diclofenac.", "recall_initiation_date": "20241104", "center_classification_date": "20241202", "report_date": "20241211", "code_info": "Lot #: 230811, Exp: 08/11/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Pennington", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA206055"], "brand_name": ["ESOMEPRAZOLE MAGNESIUM"], "generic_name": ["ESOMEPRAZOLE MAGNESIUM"], "manufacturer_name": ["Zydus Pharmaceuticals USA Inc."], "product_ndc": ["68382-848", "68382-849"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ESOMEPRAZOLE MAGNESIUM DIHYDRATE"], "rxcui": ["692576", "692578"], "spl_id": ["bc31956a-671b-4ca3-b9dd-1fdb03003cae"], "spl_set_id": ["190a4c5b-1547-45d7-b00b-10da4131e2e2"], "package_ndc": ["68382-848-94", "68382-849-94"], "is_original_packager": [true], "unii": ["36H71644EQ"]}, "product_type": "Drugs", "event_id": "95767", "recalling_firm": "Zydus Pharmaceuticals (USA) Inc", "address_1": "73 Route 31 N", "address_2": "", "postal_code": "08534-3601", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide.", "recall_number": "D-0102-2025", "product_description": "Esomeprazole Magnesium for Delayed-Release Oral Suspension 40 mg, 30 Single-Dose Packets, Rx Only, Manufactured by: Zydus Lifesciences Ltd. Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 68382-849-94.  Packaged in sachets", "product_quantity": "4404 packs", "reason_for_recall": "Labeling: Not Elsewhere Classified - Wrong NDC number", "recall_initiation_date": "20241114", "center_classification_date": "20241204", "report_date": "20241211", "code_info": "Lot#: M408002, Exp 05/31/2026", "more_code_info": ""}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95718", "recalling_firm": "Tailstorm Health INC", "address_1": "24416 N 19th Ave Ste 200", "address_2": "N/A", "postal_code": "85085-1400", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide Within U.S.", "recall_number": "D-0051-2025", "product_description": "BEVACIZUMAB (AVASTIN)1.25mg/0.05mL, Sterile Injection, 0.5 mL Single-Dose Syringe, Rx Only, Repackaged by: Medivant Healthcare: 24416 N 19th Ave, Phoenix, AZ, NDC 81483-0041-1", "product_quantity": "27,560 Syringes", "reason_for_recall": "Lack of Sterility Assurance", "recall_initiation_date": "20241106", "center_classification_date": "20241118", "termination_date": "20250328", "report_date": "20241127", "code_info": "Lot #: D24005, Exp. Date 20 February 2025; D24006, Exp. Date 21 February 2025; D24007, Exp. Date 22 February 2025; D24008, Exp. Date 19 March 2025; D24009, Exp. Date 20 March 2025; D24012, Exp. Date 25 April 2025."}, {"status": "Ongoing", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA207685"], "brand_name": ["JAVYGTOR"], "generic_name": ["SAPROPTERIN DIHYDROCHLORIDE"], "manufacturer_name": ["Dr. Reddys Laboratories Inc"], "product_ndc": ["43598-096"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["SAPROPTERIN DIHYDROCHLORIDE"], "rxcui": ["1486687", "2612671"], "spl_id": ["ce2e0e3a-40e4-33ed-3cad-e166dd2245a1"], "spl_set_id": ["d9f3723f-bf7d-9a72-2ef9-41c5508d6ab4"], "package_ndc": ["43598-096-30", "43598-096-04", "43598-096-05"], "is_original_packager": [true], "upc": ["0343598096049"], "unii": ["RG277LF5B3"]}, "product_type": "Drugs", "event_id": "95811", "recalling_firm": "Dr. Reddy's Laboratories, Inc.", "address_1": "107 College Rd E", "address_2": "", "postal_code": "08540-6623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0117-2025", "product_description": "Javygtor (sapropterin dihydrochloride) Tablets 100mg, 120-count bottle, Rx Only, Distributor: Dr. Reddy's Laboratories Inc., Princeton, NJ 08540 Made in India, NDC 43598-096-04.", "product_quantity": "7,233 bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications", "recall_initiation_date": "20241122", "center_classification_date": "20241212", "report_date": "20241218", "code_info": "Lot #: T2300653, Exp 01/31/2025; T2303956, T2303750, Exp 06/30/2025; T2304190, T2304987, Exp 08/31/2025; T2302026, Exp 03/31/2025; T2302526, Exp 05/31/2025.", "more_code_info": ""}, {"status": "Ongoing", "city": "Baltimore", "state": "MD", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95610", "recalling_firm": "Lupin Pharmaceuticals Inc.", "address_1": "Harborplace Tower", "address_2": "111 S Calvert St Fl 21st", "postal_code": "21202-6174", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to 30 wholesalers/distributors who may have further distributed the product nationwide.", "recall_number": "D-0052-2025", "product_description": "Ramipril Capsules USP 2.5 mg, a) 90 count (NDC 68180-589-09), b) 100 count NDC 68180-589-01), and c) 500 count (NDC 68180-589-02) bottles, Rx only, Manufactured for Lupin Pharmaceuticals, Inc., Baltimore, MD, Manufactured by Lupin Limited, Goa, India", "product_quantity": "112,770 bottles", "reason_for_recall": "CGMP Deviations: Active pharmaceutical ingredient was sourced from an unapproved vendor", "recall_initiation_date": "20241023", "center_classification_date": "20241119", "report_date": "20241127", "code_info": "a) NDC 68180-589-09; Lots  G326781, exp. date 30-Sep-25,  GA04468, exp. date 31-May-25  b) NDC 68180-589-01;  Lots  G326763, exp. date 30-Sep-25, GA03041, exp. date 31-Mar-26, GA03725, exp. date 30-Apr-26,  GA04402, exp. date 31-May-26,   c) NDC 68180-589-02;  Lots   G326782, exp. date 30-Sep-25,  GA04462, exp. date 31-May-26"}, {"status": "Ongoing", "city": "Pulaski", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95897", "recalling_firm": "AvKARE", "address_1": "615 N 1st St", "address_2": "", "postal_code": "38478-2403", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide", "recall_number": "D-0110-2025", "product_description": "Cinacalcet Tablets, 90 mg, 30-count bottle, Rx only, Manufactured for: AvKARE, Pulaski, TN 38478, NDC 42291-461-30", "product_quantity": "2,796 bottles", "reason_for_recall": "CGMP deviations: Presence of Nitrosamine Drug Substance Related Impurity (NDSRI), N-Nitroso-Cinacalcet above acceptable intake limit.", "recall_initiation_date": "20241127", "center_classification_date": "20241205", "report_date": "20241211", "code_info": "Lot #: 44405, Exp 12/31/2024", "more_code_info": ""}, {"status": "Ongoing", "city": "Baltimore", "state": "MD", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95610", "recalling_firm": "Lupin Pharmaceuticals Inc.", "address_1": "Harborplace Tower", "address_2": "111 S Calvert St Fl 21st", "postal_code": "21202-6174", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to 30 wholesalers/distributors who may have further distributed the product nationwide.", "recall_number": "D-0053-2025", "product_description": "Ramipril Capsules USP 5 mg, a) 90 count (NDC 68180-590-09), b) 100 count NDC 68180-590-01), and c) 500 count (NDC 68180-590-02) bottles, Rx only, Manufactured for Lupin Pharmaceuticals, Inc., Baltimore, MD, Manufactured by Lupin Limited, Goa, India", "product_quantity": "146,322 bottles", "reason_for_recall": "CGMP Deviations: Active pharmaceutical ingredient was sourced from an unapproved vendor", "recall_initiation_date": "20241023", "center_classification_date": "20241119", "report_date": "20241127", "code_info": "a) NDC 68180-590-09;  Lots  G326928, exp. date 30-Sep-25,  GA00964, exp. date 31-Dec-25,   b) NDC 68180-590-01,  Lots  G326897, G326929, exp. date 30-Sep-25,  GA00854, GA00933, GA00954, exp. date 31-Dec-25,   c) NDC 68180-590-02,  Lot GA00955, exp. date 31-Dec-25"}, {"status": "Ongoing", "city": "North Chicago", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95332", "recalling_firm": "AbbVie Inc.", "address_1": "1 N Waukegan Rd", "address_2": "", "postal_code": "60064-1802", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA, Foreign Consignees (Austrailia, Canada, Great Britain)", "recall_number": "D-0664-2024", "product_description": "Refresh P.M., (Mineral Oil 42.5%, White Petrolatum 57.3%) Lubricant Eye Ointment, Net wt, 0.12 oz (3.5g) Tube, Distributed by: Allergen, an AbbVie company, Madison, NJ 07940,  UPC code: 300230667043,", "product_quantity": "2,473,563 tubes", "reason_for_recall": "Lack of Assurance of Sterility: The impacted lots may contain a breach in the tube seal.", "recall_initiation_date": "20240916", "center_classification_date": "20240923", "report_date": "20241002", "code_info": "Lot:          387392, 387393, 387394,  Exp. Feb 25; 387395, 388729, 388730, 388731, 388732, 390391, 390404, Exp. Apr 25; 391688, 391734,  Exp. Oct 25; 392616, 392620, Exp. Dec 25; 392987, 393560,  Exp. Jan 26; 394816, 394821, Exp. Nov 25; 394927, 394929, Exp. Feb 26; 395713, 395992, 396815, Exp. Mar 26; 396816,  397248, 397315, Exp. Apr 26; 397316, 397774, 397775, 397776, 398436, 398437, Exp. May 26; 398621, 398643, 398739, 398944, 399001, 399255, 399270, 399271, Exp. Jun 26; 399798, 399806, 400003, Exp. Jul 26; 408668, 408723, 408737, 408853, 408895, Exp. Apr 27; 409121, 409142, Exp. May 27; 409261, Exp. Apr 27; T4534, T4535, T4591, T4592, Exp. Dec 24; T4660, T4661, T4696, T4697, T4709, T4772, T4773, Exp. Jan 25; T4844, T4845, Feb 25", "more_code_info": ""}, {"status": "Ongoing", "city": "Warren", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95611", "recalling_firm": "Cipla USA, Inc.", "address_1": "10 Independence Blvd", "address_2": "N/A", "postal_code": "07059-2730", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-0043-2025", "product_description": "Lanthanum Carbonate Chewable Tablets, 1000mg, 10-count bottle, Rx only, Manufactured for Cipla USA, NDC 69097-0936-98", "product_quantity": "1,875 boxes (cipla and exlan)", "reason_for_recall": "Failed Tablet/Capsule Specifications: Complaints received of crushed and broken tablets.", "recall_initiation_date": "20241023", "center_classification_date": "20241112", "report_date": "20241120", "code_info": "Lot # NB240316, Exp 12/31/25"}, {"status": "Ongoing", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA208040"], "brand_name": ["DABIGATRAN ETEXILATE"], "generic_name": ["DABIGATRAN ETEXILATE"], "manufacturer_name": ["Ascend Laboratories, LLC"], "product_ndc": ["67877-474", "67877-475", "67877-624"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DABIGATRAN ETEXILATE MESYLATE"], "rxcui": ["1037045", "1037179", "1723476"], "spl_id": ["dd84fc7b-8d68-4a2b-ab48-9458f6586160"], "spl_set_id": ["3a8ec82a-c367-40dc-9302-e1896fcb05ea"], "package_ndc": ["67877-475-60", "67877-474-60", "67877-624-60", "67877-624-31"], "is_original_packager": [true], "unii": ["SC7NUW5IIT"]}, "product_type": "Drugs", "event_id": "95896", "recalling_firm": "Ascend Laboratories, LLC", "address_1": "339 Jefferson Rd Ste 101", "address_2": "", "postal_code": "07054-3707", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0130-2025", "product_description": "Dabigatran Etexilate, 150mg capsules, 60-count bottles, Rx Only, Manufactured by: Alkem Laboratories Ltd., INDIA, Distributed by: Ascend Laboratories, LLC Parsippany, NJ 07054 NDC 67877-475-60", "product_quantity": "10,444 bottles", "reason_for_recall": "CGMP Deviations: Presence of N-nitroso-Dabigatran impurity above recommended interim limit", "recall_initiation_date": "20241212", "center_classification_date": "20241212", "report_date": "20241218", "code_info": "Lot #: 24142192, 24142193, 24142194, Exp. Date April 30, 2026; 24142463, Exp. Date May 31, 2026;", "more_code_info": ""}, {"status": "Ongoing", "city": "Gibbstown", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95854", "recalling_firm": "Keystone Industries", "address_1": "480 S Democrat Rd", "address_2": "", "postal_code": "08027-1239", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the USA and Canada, Dominican Republic, El Salvador, Honduras, and Qatar.", "recall_number": "D-0144-2025", "product_description": "Pearson Quality, Topical Anesthetic Gel, 20% Benzocaine, For Professional Use Only, Net Contents: 1 oz (30 g), Manufactured for Pearson Dental Supply Inc., Sylmar, CA 91342 USA.", "product_quantity": "", "reason_for_recall": "CGMP deviations: the bulk product was rejected by the Quality Unit after routine inspection of the mixing vessel showed scratches on the sides and bottom of the mixing vessel. Product was to be rejected but was inadvertently released and shipped to customers.", "recall_initiation_date": "20241114", "center_classification_date": "20241213", "report_date": "20241225", "code_info": "Lot: BNZ-001646, Exp Date: 11/26/2026, Keystone Item No. 03-30619", "more_code_info": ""}, {"status": "Ongoing", "city": "National City", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95520", "recalling_firm": "C & A Naturistics", "address_1": "2424 Hoover Ave Ste N", "address_2": "N/A", "postal_code": "91950-8575", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0024-2025", "product_description": "AK Forte Ortiga y Omega 3 Cont. Neto 100 Tabletas, 400 mg,", "product_quantity": "Unknown", "reason_for_recall": "Marketed without an Approved NDA/ANDA: FDA analysis found the product to be tainted with undeclared diclofenac and acetaminophen.", "recall_initiation_date": "20241008", "center_classification_date": "20241022", "report_date": "20241030", "code_info": "All Lots", "more_code_info": ""}, {"status": "Ongoing", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA208040"], "brand_name": ["DABIGATRAN ETEXILATE"], "generic_name": ["DABIGATRAN ETEXILATE"], "manufacturer_name": ["Ascend Laboratories, LLC"], "product_ndc": ["67877-474", "67877-475", "67877-624"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DABIGATRAN ETEXILATE MESYLATE"], "rxcui": ["1037045", "1037179", "1723476"], "spl_id": ["dd84fc7b-8d68-4a2b-ab48-9458f6586160"], "spl_set_id": ["3a8ec82a-c367-40dc-9302-e1896fcb05ea"], "package_ndc": ["67877-475-60", "67877-474-60", "67877-624-60", "67877-624-31"], "is_original_packager": [true], "unii": ["SC7NUW5IIT"]}, "product_type": "Drugs", "event_id": "95896", "recalling_firm": "Ascend Laboratories, LLC", "address_1": "339 Jefferson Rd Ste 101", "address_2": "", "postal_code": "07054-3707", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0129-2025", "product_description": "Dabigatran Etexilate, 75 mg capsules, 60-count bottles, Rx Only, Manufactured by: Alkem Laboratories Ltd., INDIA, Distributed by: Ascend Laboratories, LLC Parsippany, NJ 07054 NDC 67877-474-60", "product_quantity": "1971 bottles", "reason_for_recall": "CGMP Deviations: Presence of N-nitroso-Dabigatran impurity above recommended interim limit", "recall_initiation_date": "20241212", "center_classification_date": "20241212", "report_date": "20241218", "code_info": "Lot #: 24142328, 24142329, 24142330, Exp. Date May 31, 2026.", "more_code_info": ""}, {"status": "Terminated", "city": "New Delhi", "state": "", "country": "India", "classification": "Class II", "openfda": {"application_number": ["M017"], "brand_name": ["EQUATE PAIN RELIEVING PATCHES"], "generic_name": ["LIDOCAINE 4%"], "manufacturer_name": ["WALMART, INC"], "product_ndc": ["79903-106"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL", "TRANSDERMAL"], "substance_name": ["LIDOCAINE"], "rxcui": ["1737778"], "spl_id": ["40ab0cc1-c748-7bb4-e063-6294a90ab3c6"], "spl_set_id": ["d91cc701-5e0a-d6c2-e053-2a95a90a9e75"], "package_ndc": ["79903-106-06"], "is_original_packager": [true], "nui": ["N0000175682", "M0000897", "N0000175426", "N0000175976"], "pharm_class_epc": ["Amide Local Anesthetic [EPC]", "Antiarrhythmic [EPC]"], "pharm_class_cs": ["Amides [CS]"], "pharm_class_pe": ["Local Anesthesia [PE]"], "unii": ["98PI200987"], "upc": ["681131071277"]}, "product_type": "Drugs", "event_id": "95595", "recalling_firm": "Unexo Life Sciences Private Limited", "address_1": "B16, Sector 4, Bawana Industrial Area", "address_2": "", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0068-2025", "product_description": "EQUATE MAXIMUM STRENGTH LIDOCAINE PAIN RELIEVING PATCH Lidocaine 4% Topical Anesthetic, 6 patches per box PATCHES, LIDOCAINE 4%, Distributed by: Walmart Inc., Bentonville, AR 72716 NDC 79903-106-06", "product_quantity": "1,101,600 patches", "reason_for_recall": "cGMP Deviations", "recall_initiation_date": "20241024", "center_classification_date": "20241122", "termination_date": "20250916", "report_date": "20241204", "code_info": "UPC 6 81131 07127 7", "more_code_info": ""}, {"status": "Ongoing", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA208368"], "brand_name": ["CINACALCET"], "generic_name": ["CINACALCET"], "manufacturer_name": ["Dr. Reddys Laboratories Inc"], "product_ndc": ["43598-367", "43598-368", "43598-369"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CINACALCET HYDROCHLORIDE"], "rxcui": ["432400", "432401", "432402"], "spl_id": ["b6dbd55a-a71d-0cf8-2c73-7ebbfc032906"], "spl_set_id": ["0837aabc-e796-0e07-8958-71f1ff6e89bf"], "package_ndc": ["43598-367-30", "43598-367-05", "43598-368-30", "43598-368-05", "43598-369-30", "43598-369-05"], "is_original_packager": [true], "upc": ["0343598369303"], "unii": ["1K860WSG25"]}, "product_type": "Drugs", "event_id": "95500", "recalling_firm": "Dr. Reddy's Laboratories, Inc.", "address_1": "107 College Rd E", "address_2": "N/A", "postal_code": "08540-6623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide.", "recall_number": "D-0028-2025", "product_description": "Cinacalcet Tablets, 90 mg, 30-count bottle, Rx Only, Dr. Reddy's Laboratories Inc, Princeton, NJ 08540, Made in India., NDC 43598-369-30.", "product_quantity": "10584 bottles", "reason_for_recall": "CGMP Deviations: Presence of N-nitroso Cinacalcet impurity above FDA recommended interim limit", "recall_initiation_date": "20241009", "center_classification_date": "20241028", "report_date": "20241106", "code_info": "Lot# T2201443, Exp 03/2025; T2300664, Exp 12/2025.", "more_code_info": ""}, {"status": "Ongoing", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95588", "recalling_firm": "Dr. Reddy's Laboratories, Inc.", "address_1": "107 College Rd E", "address_2": "N/A", "postal_code": "08540-6623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "N/A", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0036-2025", "product_description": "Morphine Sulfate Extended-Release Tablets 15 mg,  100-count per bottle, Rx Only, Manufactured by Mayne Pharma, Greenville, NC 27834, NDC 51862-185-01.", "product_quantity": "2,040 100-count bottles", "reason_for_recall": "Failed Impurities/Degradation Specification", "recall_initiation_date": "20241022", "center_classification_date": "20241104", "report_date": "20241113", "code_info": "Lot#  FG14062, Exp 10/31/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Woburn", "state": "MA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95659", "recalling_firm": "Safecor Health, LLC", "address_1": "317 New Boston St", "address_2": "N/A", "postal_code": "01801-6231", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-0060-2025", "product_description": "Docusate Sodium 250 mg, 1 Softgel in blister card-foils, 100-count unit dose box, www.safecorhealth.com, NDC 48433-101-01", "product_quantity": "587 boxes", "reason_for_recall": "cGMP Deviations: Observations were made that some blister card-foils were separating from the blister cavity.", "recall_initiation_date": "20241111", "center_classification_date": "20241119", "report_date": "20241127", "code_info": "Lot# 34A0054, exp. date 05/07/2026"}, {"status": "Terminated", "city": "Canton", "state": "MA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95427", "recalling_firm": "Fresenius Kabi Compounding, LLC", "address_1": "20 Dan Rd", "address_2": "N/A", "postal_code": "02021-2809", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to 125 direct accounts nationwide.", "recall_number": "D-0019-2025", "product_description": "NORepinephrine Bitartrate 0.9% Sodium Chloride Injection USP, 4 mg per 250 mL, Single Dose Bag, Rx only, Fagron Sterile Services, Canton, MA NDC: 71506-025-58", "product_quantity": "2151 bags", "reason_for_recall": "cGMP violations", "recall_initiation_date": "20240925", "center_classification_date": "20241021", "termination_date": "20250815", "report_date": "20241030", "code_info": "Lot # C274-000038582, exp. date 29-Nov-24", "more_code_info": ""}, {"status": "Ongoing", "city": "Hicksville", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95824", "recalling_firm": "Apothecus Pharmaceutical Corp.", "address_1": "485 S Broadway Ste 27", "address_2": "", "postal_code": "11801-5071", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and 2 Distributors in Hong Kong", "recall_number": "D-0151-2025", "product_description": "VCF, Vaginal Contraceptive Gel, Birth Control, 10 Pre-filled Applicators, Net Wt. 0.09 oz (2.55g) Each, Distributed By: Apothecus Pharmaceutical Corp., Ronkonkoma, NY 11779, NDC 52925-512-10", "product_quantity": "33,659 retail boxes in US", "reason_for_recall": "CGMP deviations: out of specifications for assay", "recall_initiation_date": "20241122", "center_classification_date": "20241217", "report_date": "20241225", "code_info": "Lot: 3A001/3A001A, Exp: 07/25", "more_code_info": ""}, {"status": "Ongoing", "city": "Cranford", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA214019"], "brand_name": ["DAPSONE"], "generic_name": ["DAPSONE"], "manufacturer_name": ["Viona Pharmaceuticals Inc"], "product_ndc": ["72578-094"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TOPICAL"], "substance_name": ["DAPSONE"], "rxcui": ["1741905"], "spl_id": ["fbed711e-945e-46aa-8883-fee0b7604485"], "spl_set_id": ["30867c69-cf3c-4360-8e56-db96e0b0c3ab"], "package_ndc": ["72578-094-01", "72578-094-02", "72578-094-03"], "is_original_packager": [true], "nui": ["N0000175881", "M0020791"], "pharm_class_epc": ["Sulfone [EPC]"], "pharm_class_cs": ["Sulfones [CS]"], "unii": ["8W5C518302"]}, "product_type": "Drugs", "event_id": "95412", "recalling_firm": "VIONA PHARMACEUTICALS INC", "address_1": "20 Commerce Dr Ste 340", "address_2": "", "postal_code": "07016-3617", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "", "distribution_pattern": "NY", "recall_number": "D-0011-2025", "product_description": "Dapsone Gel 7.5%, 60 gram pump, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India, Distributed by: Viona Pharmaceuticals Inc., Cranford, NJ 07016, NDC 72578-094-02.", "product_quantity": "2544 pumps", "reason_for_recall": "Crystallization", "recall_initiation_date": "20240924", "center_classification_date": "20241012", "report_date": "20241023", "code_info": "Lot #: T400512, Exp 02/28/2026", "more_code_info": ""}, {"status": "Ongoing", "city": "Gibbstown", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95854", "recalling_firm": "Keystone Industries", "address_1": "480 S Democrat Rd", "address_2": "", "postal_code": "08027-1239", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the USA and Canada, Dominican Republic, El Salvador, Honduras, and Qatar.", "recall_number": "D-0138-2025", "product_description": "M&S Dental Supply Co LLC., Topical Anesthetic Gel, Benzocaine 20%, Net Wt. 1 oz. (30ml), Manufactured for: M&S Dental Supply Co LL, 105-30 101 Avenue, Ozone Park, NY 11416.", "product_quantity": "", "reason_for_recall": "CGMP deviations: the bulk product was rejected by the Quality Unit after routine inspection of the mixing vessel showed scratches on the sides and bottom of the mixing vessel. Product was to be rejected but was inadvertently released and shipped to customers.", "recall_initiation_date": "20241114", "center_classification_date": "20241213", "report_date": "20241225", "code_info": "Lot: BNZ-001646, Exp Date: 11/26/2026, Keystone Item No: 03-09619", "more_code_info": ""}, {"status": "Completed", "city": "Berlin", "state": "CT", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA203088"], "brand_name": ["DULOXETINE"], "generic_name": ["DULOXETINE HYDROCHLORIDE"], "manufacturer_name": ["Breckenridge Pharmaceutical, Inc."], "product_ndc": ["51991-746", "51991-747", "51991-748", "51991-750"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DULOXETINE HYDROCHLORIDE"], "rxcui": ["596926", "596930", "596934", "616402"], "spl_id": ["32327581-bdab-41ac-9adc-bf208e1c4e42"], "spl_set_id": ["caef6f50-1571-4ec7-8f8c-42b924d323ee"], "package_ndc": ["51991-746-06", "51991-746-90", "51991-746-05", "51991-747-33", "51991-747-90", "51991-747-10", "51991-748-33", "51991-748-90", "51991-748-10", "51991-750-33", "51991-750-90", "51991-750-05", "51991-750-10"], "is_original_packager": [true], "unii": ["9044SC542W"]}, "product_type": "Drugs", "event_id": "95508", "recalling_firm": "Breckenridge Pharmaceutical, Inc", "address_1": "15 Massirio Dr Ste 201", "address_2": "", "postal_code": "06037-2352", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed nationwide within the United States", "recall_number": "D-0009-2025", "product_description": "Duloxetine Delayed-Release Capsules, USP, 20mg, Rx Only, 500-count bottles, Mfr. by: Towa Pharmaceutical Europe, S.L. Distributed by: BPI, NDC 51991-746-05.", "product_quantity": "7,107 bottles", "reason_for_recall": "CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit", "recall_initiation_date": "20241010", "center_classification_date": "20241011", "report_date": "20241023", "code_info": "Lot #: 220128, Exp. Date 12/2024", "more_code_info": ""}, {"status": "Ongoing", "city": "East Windsor", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA211053"], "brand_name": ["NEBIVOLOL"], "generic_name": ["NEBIVOLOL"], "manufacturer_name": ["Aurobindo Pharma Limited"], "product_ndc": ["59651-137", "59651-138", "59651-139", "59651-140"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["NEBIVOLOL HYDROCHLORIDE"], "rxcui": ["387013", "751612", "751618", "827073"], "spl_id": ["8b2201ae-7174-45fe-a219-63d385d5c94b"], "spl_set_id": ["6e43a4e2-574e-4f4a-804d-e346b4edd2f1"], "package_ndc": ["59651-137-30", "59651-137-90", "59651-138-30", "59651-138-90", "59651-139-30", "59651-139-90", "59651-140-30", "59651-140-90"], "is_original_packager": [true], "upc": ["0359651137307"], "unii": ["JGS34J7L9I"]}, "product_type": "Drugs", "event_id": "95934", "recalling_firm": "Aurobindo Pharma USA Inc", "address_1": "279 Princeton Hightstown Rd", "address_2": "", "postal_code": "08520-1401", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0149-2025", "product_description": "Nebivolol Tablets, 2.5. mg, 30-count bottles, Rx only, Distributed by: Aurobindo Pharma USA, Inc., 279 Princeton-Hightstown Road, East Windsor, NJ 08520.  NDC:  59651-137-30", "product_quantity": "", "reason_for_recall": "CGMP Deviations: Presence of Nitrosamine Drug Substance Related Impurity (NDSRI), N-Nitroso Nebivolol above acceptable intake (AI) limit.", "recall_initiation_date": "20241206", "center_classification_date": "20241216", "report_date": "20241225", "code_info": "Lot #: NB0224001A and NB0224001B, Exp. Date 04/2027", "more_code_info": ""}, {"status": "Ongoing", "city": "Athens", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95826", "recalling_firm": "Midlab Incorporated", "address_1": "140 Private Brand Way", "address_2": "", "postal_code": "37303-1401", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0088-2025", "product_description": "boardwalk ANTIBACTERIAL HANDSOAP REFILL, Chloroxylenol 0.1%, 1 gal. (3.78 L), Manufactured for Essendant Co., One Parkway North, Deerfield, IL 60015", "product_quantity": "", "reason_for_recall": "cGMP Deviations: Out of specification results for micro in hand soap products.", "recall_initiation_date": "20241106", "center_classification_date": "20241202", "report_date": "20241211", "code_info": "Lot 0711241", "more_code_info": ""}, {"status": "Ongoing", "city": "Canonsburg", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA076187"], "brand_name": ["LEVOTHYROXINE SODIUM"], "generic_name": ["LEVOTHYROXINE SODIUM"], "manufacturer_name": ["Mylan Pharmaceuticals Inc."], "product_ndc": ["0378-1800", "0378-1803", "0378-1805", "0378-1807", "0378-1809", "0378-1811", "0378-1813", "0378-1823", "0378-1815", "0378-1817", "0378-1819", "0378-1821"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LEVOTHYROXINE SODIUM"], "rxcui": ["892246", "892251", "892255", "966220", "966221", "966222", "966224", "966225", "966248", "966249", "966253", "966270"], "spl_id": ["ca193039-55b1-4a7e-aa67-c4bff4f9f5b0"], "spl_set_id": ["e95720f2-91c9-a6d0-f7d5-8bcb94d07bbc"], "package_ndc": ["0378-1800-77", "0378-1800-10", "0378-1803-77", "0378-1803-10", "0378-1805-77", "0378-1805-10", "0378-1807-77", "0378-1807-10", "0378-1809-77", "0378-1809-10", "0378-1811-77", "0378-1811-10", "0378-1813-77", "0378-1813-10", "0378-1823-77", "0378-1823-10", "0378-1815-77", "0378-1815-10", "0378-1817-77", "0378-1817-10", "0378-1819-77", "0378-1819-10", "0378-1821-77"], "is_original_packager": [true], "unii": ["9J765S329G"]}, "product_type": "Drugs", "event_id": "95768", "recalling_firm": "Viatris Inc", "address_1": "1000 Mylan Blvd", "address_2": "", "postal_code": "15317-5853", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States and Puerto Rico", "recall_number": "D-0128-2025", "product_description": "Levothyroxine Sodium Tablets USP, 112 mcg, packaged in a) 90-count bottles (NDC 0378-1811-77) and b) 1000-count bottles (NDC 0378-1811-10), Rx only, Manufactured for: Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A.", "product_quantity": "35,883 bottles", "reason_for_recall": "Superpotent Drug and Subpotent Drug: potency failures obtained", "recall_initiation_date": "20241118", "center_classification_date": "20241212", "report_date": "20241218", "code_info": "Lot #: a) 8171623, Exp. Date Feb 2025; 8164486, Exp. Date Nov 2024 b)3205462, Exp. Date Aug 2025; 3192428, Exp. Date Feb 2025; 3184096, Exp. Date Nov 2024", "more_code_info": ""}, {"status": "Ongoing", "city": "Sacramento", "state": "CA", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "95714", "recalling_firm": "Boulla LLC", "address_1": "2108 N ST #7929", "address_2": "", "postal_code": "95816", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0084-2025", "product_description": "PeakMax Capsules, 500 mg, packaged in 10 count blisters in cartons, Distributed by: PeakMax, San Francisco, CA, www.PeakMax.com", "product_quantity": "Unknown", "reason_for_recall": "Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and diclofenac.", "recall_initiation_date": "20241104", "center_classification_date": "20241202", "report_date": "20241211", "code_info": "Lot #: 230811, Exp: 08/11/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Canonsburg", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA076187"], "brand_name": ["LEVOTHYROXINE SODIUM"], "generic_name": ["LEVOTHYROXINE SODIUM"], "manufacturer_name": ["Mylan Pharmaceuticals Inc."], "product_ndc": ["0378-1800", "0378-1803", "0378-1805", "0378-1807", "0378-1809", "0378-1811", "0378-1813", "0378-1823", "0378-1815", "0378-1817", "0378-1819", "0378-1821"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LEVOTHYROXINE SODIUM"], "rxcui": ["892246", "892251", "892255", "966220", "966221", "966222", "966224", "966225", "966248", "966249", "966253", "966270"], "spl_id": ["ca193039-55b1-4a7e-aa67-c4bff4f9f5b0"], "spl_set_id": ["e95720f2-91c9-a6d0-f7d5-8bcb94d07bbc"], "package_ndc": ["0378-1800-77", "0378-1800-10", "0378-1803-77", "0378-1803-10", "0378-1805-77", "0378-1805-10", "0378-1807-77", "0378-1807-10", "0378-1809-77", "0378-1809-10", "0378-1811-77", "0378-1811-10", "0378-1813-77", "0378-1813-10", "0378-1823-77", "0378-1823-10", "0378-1815-77", "0378-1815-10", "0378-1817-77", "0378-1817-10", "0378-1819-77", "0378-1819-10", "0378-1821-77"], "is_original_packager": [true], "unii": ["9J765S329G"]}, "product_type": "Drugs", "event_id": "95768", "recalling_firm": "Viatris Inc", "address_1": "1000 Mylan Blvd", "address_2": "", "postal_code": "15317-5853", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States and Puerto Rico", "recall_number": "D-0121-2025", "product_description": "Levothyroxine Sodium Tablets USP, 175 mcg, packaged in a) 90-count bottles (NDC 0378-1817-77) and b) 1000-count bottles (NDC 0378-1817-10), Rx only, Manufactured for: Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A.", "product_quantity": "19, 549 bottles", "reason_for_recall": "Superpotent Drug and Subpotent Drug: potency failures obtained", "recall_initiation_date": "20241118", "center_classification_date": "20241212", "report_date": "20241218", "code_info": "Lot #: a) 3192915, 8172108, Exp. Date Mar 2025; b) 3208680, Exp. Date Sep 2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Gibbstown", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95854", "recalling_firm": "Keystone Industries", "address_1": "480 S Democrat Rd", "address_2": "", "postal_code": "08027-1239", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the USA and Canada, Dominican Republic, El Salvador, Honduras, and Qatar.", "recall_number": "D-0147-2025", "product_description": "Ipana, 20% Benzocaine Topical Gel, 28g, Maxill Inc., St Thomas ON Canada.", "product_quantity": "", "reason_for_recall": "CGMP deviations: the bulk product was rejected by the Quality Unit after routine inspection of the mixing vessel showed scratches on the sides and bottom of the mixing vessel. Product was to be rejected but was inadvertently released and shipped to customers.", "recall_initiation_date": "20241114", "center_classification_date": "20241213", "report_date": "20241225", "code_info": "Lot No.: BNZ-001646, Exp Date: 11/26/2026, Keystone Item No. 03-35119", "more_code_info": ""}, {"status": "Ongoing", "city": "Miami", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA215401"], "brand_name": ["XELSTRYM"], "generic_name": ["DEXTROAMPHETAMINE"], "manufacturer_name": ["Noven Therapeutics, LLC"], "product_ndc": ["68968-0205", "68968-0210", "68968-0215", "68968-0220"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TRANSDERMAL"], "substance_name": ["DEXTROAMPHETAMINE"], "spl_id": ["368e7b16-6dbd-4fe7-b2b1-732123f5fdf3"], "spl_set_id": ["0862f02a-72a8-41cc-8845-57cf4974bb6f"], "package_ndc": ["68968-0205-1", "68968-0205-3", "68968-0210-1", "68968-0210-3", "68968-0215-1", "68968-0215-3", "68968-0220-1", "68968-0220-3"], "is_original_packager": [true], "nui": ["N0000175739", "N0000175729"], "pharm_class_epc": ["Central Nervous System Stimulant [EPC]"], "pharm_class_pe": ["Central Nervous System Stimulation [PE]"], "unii": ["TZ47U051FI"]}, "product_type": "Drugs", "event_id": "95701", "recalling_firm": "Noven Pharmaceuticals Inc", "address_1": "11960 Sw 144th St", "address_2": "N/A", "postal_code": "33186-6109", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-0055-2025", "product_description": "Xelstrym (dextroamphetamine) transdermal system, 13.5 mg dextroamphetamine/9 hours, 30 individually sealed transdermal patches, inside a foil-sealed polypropylene tray, packed in a paper carton/box, MANUFACTURED BY NOVEN PHARMACEUTICALS, INC., Miami, FL 33186 United Sates, NDC 68968-0215-3", "product_quantity": "685 boxes", "reason_for_recall": "Defective Delivery System: The product does not meet predetermined specifications for Coldflow (adhesive).", "recall_initiation_date": "20241031", "center_classification_date": "20241119", "report_date": "20241127", "code_info": "Lot # 95598, Exp 02/28/25"}, {"status": "Terminated", "city": "New Delhi", "state": "", "country": "India", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95595", "recalling_firm": "Unexo Life Sciences Private Limited", "address_1": "B16, Sector 4, Bawana Industrial Area", "address_2": "", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0070-2025", "product_description": "JR WATKINS COOLING PAIN RELIEF PATCHES, Menthol 7.5%, 5 patches per box, Distributed By: J.R. Watkins, LLC, Oakland, CA 94612 UPC 8 56294 00878 5", "product_quantity": "10,368 patches", "reason_for_recall": "cGMP Deviations", "recall_initiation_date": "20241024", "center_classification_date": "20241122", "termination_date": "20250916", "report_date": "20241204", "code_info": "UPC 8 56294 00878 5", "more_code_info": ""}]